Prevalence and antimicrobial resistance profile of non-typhoidal Salmonella in pigs in Kenya and Malawi by Wilson, CN
		
Prevalence	and	antimicrobial	resistance	
profile	of	non-typhoidal	Salmonella	in	
pigs	in	Kenya	and	Malawi	
	
Thesis	submitted	in	accordance	with	the	requirements	of	the	
University	of	Liverpool	for	the	degree	of	Master	in	Philosophy	
	
By	
	Catherine	Nicole	Wilson	
	
February	2018	
	
	
	
	
	
	
	
	 2	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 3	
Table	of	Contents	
	
Acknowledgements	 	 	 	 	 	 	 	 	 	 4	
Abbreviations	 	 	 	 	 	 	 	 	 	 	 5	
Abstract	 	 	 	 	 	 	 	 	 	 	 6	
Chapter	1:	General	Introduction	and	literature	review	 	 	 	 	 	 8	
Chapter	2:	Materials	and	Methods	 	 	 	 	 	 	 	 32	
Chapter	3:	Results	 	 	 	 	 	 	 	 	 	 40	
Chapter	4:	Discussion	 	 	 	 	 	 	 	 	 	 56	
References	 	 	 	 	 	 	 	 	 	 	 67	
Appendices	 	 	 	 	 	 	 	 	 	 	 95	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	 4	
	
	
Acknowledgements	
	
There	are	many	people	 to	whom	I	am	extremely	grateful	 to	 for	 their	help	and	support	during	this	
project.	 The	 assistance	 and	 expertise	 of	 fellow	 students	 and	 laboratory	 staff	 at	 the	 University	 of	
Liverpool,	 International	 Livestock	 Research	 Centre,	 Nairobi	 and	 the	 Malawi	 Liverpool	 Wellcome	
Trust	 Centre	 is	 greatly	 appreciated.	 	 Thanks	 to	 Professor	 Jay	 Hinton	 and	 Caisey	 Pulford	 for	 their	
assistance	 with	 the	 genetic	 analysis	 component	 of	 this	 project	 and	 James	 Akoko	 and	 Milicent	
Ojwang,	 ‘The	Flying	Team’,	for	their	essential	help	with	sample	collection	in	Busia,	Nairobi	and	the	
Chikwawa	Valley.		
	
This	 project	 would	 not	 have	 been	 possible	 without	 the	 funding	 provided	 by	 the	Wellcome	 Trust	
Institutional	 Strategic	 Support	 Fund	 for	 this	 ‘Research	 Taster	 Fellowship’,	 to	 which	 I	 am	 entirely	
grateful.		
	
Specific	thanks	to	my	supervisors	Professor	Eric	Fèvre,	Dr.	Gina	Pinchbeck,	Professor	Paul	Wigley	and	
Professor	Melita	Gordon	for	 their	help,	guidance	and	support	 throughout	the	entire	course	of	 this	
project.	
	
	
	
	
	
	
	
	
	
	 5	
Abbreviations	
	
AMOXY-
CLAV	
amoxicillin-clavulanate	 EUCAST
	 	
European	Committee	on	
Antimicrobial	Susceptibility	Testing	
AMP	 ampicillin	 GENT	 gentamicin	
BGA	 brilliant	green	agar	 GPS	 Global	positioning	system	
CEFOT	 cefoxitin	 HAC	 Harlequin	chromogenic	agar	
CTX	 cefotaxime	 HIV	 human	immunodeficiency	virus	
CAZ	 ceftazidime	 HMIC	 higher	middle	income	countries	
	
CHLOR	 chloramphenicol	 ILRI	 International	Livestock	Research	
Institute	
CIPRO	 ciprofloxacin	 iNTS	 invasive	non-typhoidal	Salmonella	
CLSI	 Clinical	Laboratory	Standards	
Institute	
ISO	 International	Organisation	for	
Standardisation	
Dfr	 dihydrofolate	reductase	 KANA	 kanamycin	
DNA	 deoxyribonucleic	acid	
	
LMIC	 lower	middle	income	countries	
DVS-ILRI	 Department	of	Veterinary	
Services	-	International	Livestock	
Research	Institute	
MDR	 multi-drug	resistant	
ESBL	 extended-spectrum	beta-
lactamase	
MLN	 mesenteric	lymph	node	
EU	 European	Union	 N	 total	number	
	 6	
NTS	 non-typhoidal	Salmonella	 WGS	 whole	genome	sequencing	
PCR	 polymerase	chain	reaction	
SGI-1	 Salmonella	pathogenicity	island-
1	
	
sSA	 sub-Saharan	Africa	
ST	 sequence	type	
STREP	 streptomycin	
TET	 tetracycline	
TRIM	 trimethoprim-
sulphamethoxazole	
	 	
	 	
	 	 	
	 	
	
	 	
	 	
	 	
	 	
	 	
	 	
	 	
	 	 	
	 	
	 	 	
	 	
	 	 	
	 	
	 	
	 	
	 6	
Prevalence	and	anti-microbial	resistance	(AMR)	profile	of	non-typhoidal	Salmonella	(NTS)	
in	pigs	in	Kenya	and	Malawi	
This	 study	 shows	 that	 pigs	 at	 slaughtered	 in	Busia	 and	Nairobi,	 Kenya	 and	 the	Chikwawa	
Valley,	 Malawi	 carry	 a	 variety	 of	 non-typhoidal	 Salmonella	 (NTS)	 serovars	 with	 assorted	
AMR	profiles,	including	MDR	phenotypes.		
Non-typhoidal	Salmonella	(NTS)	has	a	huge	global	disease	burden	in	humans,	particularly	in	
sub-Saharan	 Africa,	 and	 antimicrobial	 resistant	 strains	 are	 commonly	 found.	 	 There	 is	
suspicion	that	human-human	transmission	may	not	be	the	sole	route	of	spread	of	NTS;	this	
study	investigates	whether	pigs	may	act	as	a	potential	source	of	transmission.	The	main	aim	
of	this	work	was	to	determine	and	compare	prevalence,	strains	and	diversity	of	NTS	in	pig	
samples	collected	at	post	mortem	from	3	slaughter	house	sites;	two	rural	(Busia,	Kenya	and	
the	Chikwawa	Valley,	Malawi)	and	one	urban	(Nairobi,	Kenya)	areas.		The	secondary	aim	of	
this	 project	was	 to	 determine	 and	 compare	 the	 antimicrobial	 resistance	 profile	 (AMR)	 of	
NTS	present.	
Faecal	 and	 mesenteric	 lymph	 node	 samples	 were	 collected	 from	 pigs	 at	 slaughter	 from	
three	 sites	 (Busia=267,	 Nairobi=306	 and	 Chikwawa	 Valley=65).	 Microbiological	 and	
molecular	analyses	including	whole	genome	sequencing	were	performed	to	determine	the	
presence	of	non-typhoidal	Salmonella	and	the	AMR	profile	of	any	NTS	detected.	A	variety	of	
zoonotic	 serovars	 of	NTS	were	detected	 in	 faecal	 and	mesenteric	 lymph	nodes	of	 pigs	 at	
each	site,	including	S.	Typhimurium	and	S.	Enteritidis.		One	isolate	of	S.	Typhimurium	ST313	
was	identified	in	the	mesenteric	lymph	node	of	a	pig	slaughtered	in	Nairobi,	Kenya	and	four	
unique	isolates	of	S.	Typhimurium	ST19	were	detected	in	pigs	at	slaughter	in	Nairobi.	Only	
partial	whole	genome	sequencing	results	from	each	of	the	three	sites	have	currently	been	
returned.		Using	these	partial	results,	the	current	prevalence	of	fully	confirmed	NTS	isolates	
found	in	pigs	is	36.1%	(22/61,	CI	24.0-48.1%)	of	pigs	in	Nairobi	(54.5%	(12/22)	of	these	from	
mesenteric	 lymph	node	samples	and	45.5%	(10/22)	from	faeces)	and	67%	(39/61,	CI	51.9-
76.0%)	of	pigs	 in	Busia	(71.8%	(28/39)	of	these	from	mesenteric	 lymph	node	samples	and	
28.2%	(11/39)	from	faecal	samples).	No	whole	genome	sequence	results	have	yet	returned	
from	Malawi.	
Two	multi-drug	resistant	(MDR)	isolates	(resistant	to	three	or	more	classes	of	antibiotics)	of	
NTS	 were	 detected	 in	 pigs	 slaughtered	 in	 Busia.	 	 10%	 of	 current	 confirmed	 NTS	 isolates	
from	Busia	(4/39,	CI	4-24%)	and	14%	of	current	confirmed	NTS	isolates	from	Nairobi	(3/22,	
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CI	 5-3%)	 were	 resistant	 to	 1-2	 antimicrobials.	 A	 range	 of	 different	 antimicrobial	
susceptibility	 phenotypes	 were	 present,	 including	 resistance	 to	 the	 third-generation	
cephalosporin	ceftazidime	(1/61,	1.6%,	CI	0.3-8.7%	of	total	confirmed	unique	NTS	isolates)	
and	the	fluoroquinolone	ciprofloxacin	(2/61,	3.3%,	CI	0.9-11.2%	of	total	confirmed	unique	
NTS	isolates).	
This	study	concludes	that	pigs	in	Kenya	carry	and	shed	a	higher	prevalence	of	NTS	in	both	
faeces	and	mesenteric	lymph	node	than	has	previously	been	reported.		Currently	it	appears	
that	there	is	a	higher	level	of	NTS	carried	and	shed	by	pigs	in	mesenteric	lymph	nodes	from	
Busia	 than	 Nairobi.	 	 The	 majority	 of	 the	 serovars	 detected	 in	 this	 study	 are	 zoonotic,	
therefore	have	the	potential	to	cause	disease	in	humans	and	one	isolate	of	S.	Typhimurium	
ST313	 was	 detected	 in	 the	 mesenteric	 lymph	 node	 of	 a	 pig	 at	 slaughter	 in	 Nairobi.		
Multidrug	 resistant	 isolates	 of	 NTS,	 and	 those	 resistant	 to	 1-2	 antimicrobials,	 have	 also	
been	 detected	 in	 both	 Kenyan	 locations	 in	 this	 study.	 	 These	 findings	 raise	 public	 health	
concerns	as	pigs	 in	 close	contact	with	humans,	both	 in	 the	 field	and	during	 the	 slaughter	
and	meat	processing	process,	have	the	potential	to	transmit	these	bacteria	to	humans	and	
cause	disease.		
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Chapter	1:	General	Introduction	and	literature	review	
The	 Enterobacteriaceae	 Salmonella	 is	 a	 Gram-negative,	 rod-shaped,	 facultative	 intra-
cellular	bacteria.	S.	enterica	and	S.	bongori	are	the	two	species	which	have	been	identified.		
S.	enterica	is	divided	into	six	subspecies;	S.	enterica	enterica,	S.	e.	salamae,	S.	e.	arizonae,	S.	
e.	diarizonae,	S.	e.	houtenae,	 and	S.	e.	 indica.	 	 	 Each	 subspecies	 is	 further	 subdivided	 into	
numerous	 serovars,	 distinguished	 by	 the	 antigens	 present	 on	 their	 outer	 surface	
membranes	and	classified	by	the	Kauffman-White-Le	Minor	classification	scheme	(Grimont,	
2007).	 	 Each	 individual	 serovar	has	different	adaptations	 to	 invasion	and	virulence	within	
different	 hosts.	 	 ‘Host	 generalists’	 or	 ‘host-adapted’	 species	 cause	 less	 virulent	 clinical	
symptoms	 in	 a	 broad	 range	 of	 animal	 species,	 often	 with	 a	 low	 mortality	 rate	 (Feasey,	
2012).	 	 ‘Host	 restricted’	 species	 of	 NTS	 have	 undergone	 genome	 degradation	 and	
acquisition	 of	 specific	 virulence	 genes	 and	 are	 therefore	 able	 to	 cause	 more	 invasive,	
systemic	 clinical	 symptoms	 of	 disease	 in	 a	 restricted	 number	 of	 species.	 	 Examples	 of	 a	
host-restricted	Salmonellae	are	S.	Typhi,	which	causes	invasive	disease	only	in	humans,	and	
S.	Gallinarum,	which	causes	morbidity	and	mortality	only	in	chickens	(Uzzau,	2000).		
Non-typhoidal	 Salmonellae	 (NTS)	 are	 generally	 ‘host-generalists’,	 and	 this	 broad	 grouping	
encompasses	all	those	serovars	of	NTS	which	cause	disease,	or	are	carried	by,	a	broad	range	
of	hosts.		This	large	group	is	extremely	diverse	and	contains	over	2500	serovars,	more	than	
2300	of	which	have	the	ability	to	cause	disease	in	humans	(Porwollik,	2004).			
Clinical	disease	and	symptomatic	carriage	of	Salmonella	in	animals	
S.	enterica	is	the	main	species	of	NTS	associated	with	disease	in	warm-blooded	animals.		S.	
bongori	 has	 the	 potential	 to	 cause	 more	 frequent	 disease	 in	 reptilian	 hosts	 than	 in	
mammals,	although	rare	accounts	of	S.	bongori	 infections	of	humans	have	been	reported	
(Nastasi,	1988,	Giammanco,	2002).			
Several	animal	species	are	able	to	carry	S.	enterica	bacteria	asymptomatically	in	their	body	
for	 a	 period	 of	 time.	 	 In	 clinically	 affected	 animals,	 the	most	 commonly	 reported	 clinical	
signs	 associated	with	 disease	 are	 enteritis	 and	 systemic	 septicaemia.	 Other,	 rarer	 clinical	
presentations	 of	 salmonellosis	 in	 animals	 do	 occur,	 and	 include	 meningitis,	 respiratory	
disease,	arthritis	and	abortion.	
In	 animals,	 the	majority	 of	 the	more	highly	 pathogenic	 serovars	 of	NTS	 have	 a	 restricted	
host	range.		These	include	S.	Gallinarum	in	poultry,	S.	Abortusovis	in	sheep,	S.	Cholerasuis	in	
pigs	 and	 S.	 Dublin	 in	 cattle.	 	 Other,	 normally	 more	 host-generalist	 serotypes	 such	 as	 S.	
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Typhimurium	 and	 S.	 Enteritidis,	 are	 able	 to	 asymptomatically	 colonise	 the	 intestines	 or	
lymphoid	 tissue	 of	 less	 susceptible	 healthy	 animals,	 and	 are	 unlikely	 to	 cause	 clinical	
disease	in	these	carrier	animals.	Therefore,	prevalence	of	these	serotypes	in	carrier	animals	
is	often	higher	than	the	incidence	of	clinical	disease.			
Different	 species	 of	 animals	 remain	 asymptomatic	 carriers	 of	 the	 bacteria	 for	 varying	
lengths	 of	 time.	 	 NTS	may	 be	 shed	 intermittently	 in	 the	 faeces	 of	 healthy	 carrier	 pigs;	 a	
veterinary	public	 health	 concern,	 as	 these	 animals	 are	 conduits	 for	 the	 spread	of	disease	
(Boyen,	 2008,	Wales,	 2011).	 	 Sheep	and	 cattle	may	 carry	Salmonella	 for	up	 to	 ten	weeks	
and	horses	for	fourteen	months.	Pigs	may	shed	NTS	in	their	faeces	for	up	to	28	weeks	with	
no	clinical	signs	(Wood,	1989).	The	rate	of	faecal	shedding	of	NTS	bacteria	may	be	increased	
in	periods	of	stress	e.g.	drought,	food	deprivation,	crowding,	parturition	or	surgery.			
Faeco-oral	transmission,	either	directly	from	other	animals	or	from	the	environment,	is	the	
normal	 route	of	NTS	 infection.	NTS	 invades	 the	enterocytes	 and	 lymphoid	 tissue,	 causing	
intracellular	 infection.	 	 NTS	 has	 the	 ability	 to	 survive	 and	 multiply	 within	 vacuoles	 of	
macrophages	(Cirillo,	1998)	and	so	evade	immune	detection.	In	susceptible	animals,	when	
infected	 macrophages	 enter	 the	 blood	 stream,	 systemic	 septicaemia	 may	 occur	 or	 the	
bacteria	may	localise	to	other	parts	of	the	body	including	the	meninges,	reproductive	tract	
and	joints.		
Salmonella	infection	in	pigs	
NTS	 infection	 in	 commercially	 raised	 pigs	 has	 been	 a	 concern	 for	 a	 number	 of	 years	
(Josland,	1954,	O’Brien,	1966,	McKinley,	1980).		Pork	has	been	found	to	be	the	second	most	
common	 source	 of	 NTS	 for	 humans	 in	 food,	 following	 eggs	 (Pires,	 2011,	 EFSA,	 2008).	 	 A	
2013	survey	found	that	S.	Typhimurium	was	the	most	common	serovar	to	be	isolated	from	
pigs	 in	 the	 UK	 (AHVLA,	 2014).	 	 Outbreaks	 of	 disease	 caused	 by	 the	 host-adapted	 S.	
Cholerasuis	are	now	rarely	reported	in	Europe	and	Australia.			
It	is	possible	for	infection	of	pigs	to	occur	at	any	point	of	the	food	chain,	either	on	farm	or	
during	 slaughter	 and	 carcass	 processing	 (Arguello,	 2013).	 Outdoor	 rearing	 increases	 the	
likelihood	of	exposure	to	NTS	bacteria	through	the	environment,	either	from	contaminated	
feed	or	water,	 soil	 or	 birds,	 therefore	 increasing	 the	 likelihood	of	NTS	 carriage	or	 clinical	
signs	of	pigs	reared	in	these	systems.		Mathole	(2017)	found	that	meat	intended	for	human	
consumption	in	South	Africa	may	be	contaminated	by	NTS	infected	abattoir	water	effluents	
during	carcass	processing.	
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S.	Typhimurium	can	affect	pigs	 in	one	of	 three	ways.	 	 Firstly,	 immunocompetent	pigs	can	
ingest	S.	Typhimurium	and	the	bacteria	pass	passively	through	the	gut	without	invading	the	
host	intestinal	epithelium	or	establishing	infection.	Secondly,	it	is	possible	for	healthy	adult	
pigs	to	become	actively	infected	and	the	bacteria	pass	through	the	intestinal	epithelial	cells	
and	travel	to	the	mesenteric	lymph	nodes	within	hours	of	infection	(Berends,	1996);	if	the	
pig’s	immunity	is	good,	no	clinical	signs	of	infection	will	be	seen	but	the	pig	will	carry	the	S.	
Typhimurium	 bacteria	 asymptomatically.	 	 Thirdly,	 active	 clinical	 infection	 can	 occur.		
Outbreaks	of	clinical	salmonellosis	 in	pigs	on	farm	are	rare	and	can	normally	be	traced	to	
the	 introduction	 of	 one	 infected	 pig	 to	 a	 herd.	 ‘All-in-all-out’	 policies	 of	 pig	 stock	 on	
commercial	farms	helps	to	minimise	this	exposure.			
S.	Typhimurium	and	S.	Enteritidis	most	commonly	clinically	affect	piglets	up	to	six	months	
old.	Enteritis	is	the	most	common	clinical	sign,	with	or	without	septicaemia.		In	piglets	with	
low	immunity	acute	illness	may	occur,	with	depression,	pyrexia	and	death	occurring	within	
24-48	hours.	Occasionally	neurological	or	 respiratory	 signs	may	be	seen.	Depending	upon	
the	 virulence	 of	 the	 infective	 strain,	 piglet	 mortality	 may	 reach	 100%.	 In	 adults,	 acute	
enteritis	alone	without	systemic	involvement	is	more	common.		The	diarrhoea	is	often	large	
intestinal	in	nature;	severe,	watery	and	potentially	containing	mucus	and	mucus	membrane	
tissue.			
Asymptomatic	carriage	of	NTS	by	pigs	
The	presence	of	NTS	in	the	mesenteric	lymph	node	on	post	mortem	indicates	that	infection	
was	 obtained	 during	 primary	 production,	 rather	 than	 due	 to	 contamination	 at	 slaughter.	
Salmonellae	 are	most	 commonly	 carried	 by	 pigs	 in	 the	 enterocytes	 of	 the	 large	 intestine	
and	within	 the	mesenteric	 lymph	nodes	 (Nollet,	2005).	 This	provides	a	 source	which	may	
contaminate	 the	 abattoir	 environment,	 including	 other	 carcases,	 if	 good	 hygiene	
techniques	are	not	employed	(Morgan,	1987).			
A	UK	wide	survey	of	prevalence	of	NTS	carriage	in	the	ileo-caecal	lymph	nodes	of	pigs	found	
that	0-29%	carried	the	bacteria	post	mortem	(EFSA,	2008).	Studies	of	pig	production	herds	
in	Asia,	North	America	and	Africa	have	indicated	that	carriage	of	NTS	is	common	amongst	
pigs	 and	 normally	 not	 associated	 with	 clinical	 disease	 in	 these	 animals	 (Kishima,	 2008,	
Amaechi,	 2006).	 	 Should	 the	bacteria	 transfer	 to	 a	more	 susceptible	 host	 species,	 clinical	
symptoms	of	disease	may	be	seen.	 	 In	the	field	of	veterinary	public	heath,	 this	 is	 likely	to	
occur	 at	 the	 time	 of	 slaughter	 and	 carcass	 processing;	 contaminated	 pork	 products	 are	
thought	to	be	a	significant	source	of	human	infection	(Pires,	2011,	FCC,	2010).	 	Therefore,	
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accurate	 identification	of	clinically	healthy	carrier	animals	 is	a	concern	 for	 food-producing	
industries,	 as	 contamination	of	meat	products	with	pathogenic	 forms	of	NTS	may	 lead	 to	
outbreaks	of	disease.		
Diagnosis	in	pigs	
Diagnosis	 in	 cases	 of	 clinical	 disease	 in	 pigs	 includes	 consideration	 of	 clinical	 signs	 and	
isolation	 of	 the	 pathogen	 from	 faeces,	 blood	 or	 tissues,	 including	 lymphoid	 tissue.	 	 The	
most	 efficient	 method	 to	 monitor	 the	 NTS	 status	 of	 pigs	 is	 to	 carry	 out	 bacteriology	 of	
faecal	 samples,	although	serology	 is	cheaper	and	easier	 to	perform	(Alban,	2012).	 	Faecal	
bacteriology	 demonstrates	 current	 shedding	 and	 so	 the	 potential	 for	 environmental	
contamination	 or	 human	 or	 animal	 infection,	 therefore	 is	 an	 extremely	 important	
diagnostic	step	from	a	public	health	perspective.		As	faecal	shedding	may	be	intermittent,	it	
may	be	necessary	for	more	than	one	faecal	sample	to	be	collected	and	processed	in	order	
for	pathogen	identification	to	occur.			
Serological	 tests	and	PCR	assays	are	often	used	 for	 surveillance	and	diagnosis,	 identifying	
specific	serovars.	Consideration	should	be	given	that	a	serologically	positive	animal	may	no	
longer	 be	 infective,	 as	 a	 positive	 serological	 result	 indicates	 that	 the	 animal	 has	 been	
previously	 exposed	 to	 the	 bacteria,	 mounted	 an	 antibody	 response,	 and	 may	 not	 be	
shedding	the	bacteria	at	 the	time	of	sampling	 (Lo	Fo	Wong,	2003).	 	This	could	potentially	
lead	to	misclassification	of	the	herd’s	current	NTS	status.			
During	post	mortem	of	clinically	affected	pigs,	histological	 lesions,	 including	shortening	of	
villi	with	a	loss	of	the	epithelium	and	normal	intestinal	architecture,	haemorrhage	and	fibrin	
strands,	 are	mostly	 to	be	 found	 in	 the	 lower	 ileum,	 caecum	and	 spiral	 colon.	Histology	 is	
useful	for	diagnosis	of	an	individual	case	to	differentiate	from	other	causes	of	diarrhoea,	for	
example	swine	dysentery,	but	is	an	inefficient	method	to	use	in	the	case	of	herd	outbreaks	
or	discovering	the	source	of	zoonotic	outbreaks	of	disease	in	humans.	
Treatment	of	salmonellosis	in	pigs	
Early	 treatment	 of	 any	 affected	 species	 with	 antibiotics	 is	 essential	 in	 cases	 of	 clinical	
disease	 in	 order	 to	 prevent	 the	 animal	 from	 developing	 a	 carrier	 status	 and	 becoming	 a	
persistent	shedder	of	NTS	following	 initial	 infection.	Septicaemia	should	be	treated	with	a	
course	of	oral	antibiotics	for	at	 least	six	days,	normally	administered	in	the	drinking	water	
or	 intravenously.	 Effective	 antimicrobials	 to	 treat	 Salmonella-septicaemia	 in	 pigs	 include	
trimethoprim-sulphonamide,	 ampicillin	 or	 fluoroquinolones	 and	 third	 generation	
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cephalosporins,	the	latter	pair	of	which	have	a	broad-spectrum	of	action	and	should	not	be	
used	as	first-line	therapy,	 in	order	minimise	the	number	of	bacteria	which	are	affected	by	
the	 antibiotics,	 and	 so	 minimise	 the	 number	 of	 bacteria	 which	 have	 the	 potential	 to	
develop	antimicrobial	 resistance.	Phenotypic	antimicrobial	 resistance	of	NTS	 to	ampicillin,	
trimethoprim,	 sulphonamide,	 tetracyclines	 and	 aminoglycosides	 are	 usually	 caused	 by	
antimicrobial	resistance	determinants	transmitted	between	bacteria	by	plasmids.		
Oral	 treatment	 may	 be	 ineffective	 due	 to	 the	 risk	 of	 inadequate	 dosing,	 absorption	 or	
length	of	antibiotic	course,	increasing	the	risk	of	development	of	a	prolonged	carrier	state	
and	 subsequent	 intermittent	 faecal	 shedding	 of	 the	 organism,	 or	 the	 development	 of	
antimicrobial	resistance.	It	is	difficult	to	eradicate	asymptomatic	carrier	pigs	from	a	herd,	as	
they	 become	 readily	 re-infected	 by	 environmental	 exposure	 to	 the	 bacteria,	 particularly	
when	risk	factors	for	infection	such	as	being	immuno-compromised	or	if	concurrent	disease	
are	present.	
If	pigs	treated	with	antibiotics	are	destined	for	the	human	food	chain,	the	concern	 is	that	
any	 antibiotic	 resistant	 strains	 of	 NTS	may	 then	 become	 asymptomatically	 carried	 in	 the	
mesenteric	 lymph	nodes	or	 intestinal	enterocytes.	 	Selection	favouring	antibiotic	resistant	
strains	of	NTS	may	occur	due	to	treatment	with	an	antibiotic	course	of	inadequate	duration	
or	 dosage,	 use	 of	 an	 incorrect	 choice	 of	 antibiotic	 to	 treat	 a	 specific	 infection,	
administration	of	 unnecessary	 antibiotic	 treatment,	 or	 use	of	 antibiotics	 at	 a	 low	dose	 in	
animals	to	promote	growth.			These	factors	create	the	potential	for	the	transfer	of	antibiotic	
resistant	 determinants	 from	 pigs	 to	 humans,	 via	 horizontal	 transfer	 by	 conjugation,	
transformation	 or	 transduction	 either	 in	 the	 environment	 or	 the	 digestive	 system	 of	
humans	 following	pork	consumption.	 	This	 is	one	of	 the	reasons	that	use	of	antibiotics	as	
growth	 promotors	 such	 as	 tylosin	 or	 spiramycin	 have	 been	 banned	 in	 the	 EU	 in	 2006.		
Although	use	of	these	antibiotics	at	a	low	dose	in	feed	did	increase	the	growth	rate	of	the	
pigs,	recurrent	usage	of	antimicrobial	drugs	at	a	low	dose	within	a	herd	has	been	found	to	
hasten	the	development	of	antimicrobial	resistance	(Holmberg,	1984).	
Control	of	Salmonella	in	animals	
Control	 of	 Salmonella	 in	 pig	 herds	 can	 be	 broken	 up	 into	 five	 main	 categories	 of	
interventions;	 feed	management,	 acidification	 of	 food	 or	 water,	manipulation	 of	 the	 gut	
microbiota	 and	 vaccination	 (Wilhelm,	 2017).	 	Wilhelm	 (2017)	 suggested	 that	 vaccination	
and	biosecurity	management	have	the	greatest	potential	to	minimise	NTS	prevalence	on	an	
infected	 farm,	 but	 that	 only	 culling	 of	 infected	 pigs	 will	 be	 the	 strategy	 that	 eliminate	
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infection	 completely.	 	 However,	 Salmonella-free	 pigs	 are	 a	 rare	 commodity,	 and	 on	 re-
stocking,	 the	 risk	 of	 re-infection	 is	 high.	 Generally,	 it	 has	 been	 accepted	 that	 vaccination	
against	 S.	 Typhimurium	 can	 reduce	 the	 prevalence	 of	 carriage	 and	 infection,	 alongside	
implementation	 of	 other	 on-farm	 control	 measures	 (Denagamage,	 2007).	 	 The	 main	
obstacles	 in	 the	 control	of	NTS	 spread	are	 the	 frequency	of	 carrier	animals	within	a	herd	
population,	 the	 degree	 of	 environmental	 contamination,	 including	 carriage	 of	 NTS	 in	 the	
peri-domestic	wildlife	 reservoir.	Good	hygiene	and	 the	maintenance	of	healthy	herds	 can	
help	to	limit	this,	as	well	as	preventing	the	introduction	of	 infected	animals	 into	the	herd.		
Unfortunately,	 Salmonella	 spp.	 are	 often	 resistant	 to	 removal	 from	 farms	 by	 the	 normal	
cleaning	 and	 disinfection	 methods	 (Funk,	 2001).	 	 UK	 Government	 and	 EU	 supported	
programmes	have	been	introduced	in	Europe	to	reduce	and	control	infection	levels	in	food	
for	human	consumption.		In	order	to	limit	the	risk	of	introduction	of	carrier	pigs	to	a	herd,	it	
is	recommended	that	animals	should	be	purchased	from	herds	with	an	infection-free	health	
status	 and	 isolated	 for	 one	week	whilst	 their	 health	 status	 is	monitored.	However,	 there	
remains	a	risk	that	disease	may	not	become	apparent	in	carrier	animals	within	this	space	of	
time.	 It	 should	 also	 be	 ensured	 that	 food	 for	 animal	 consumption	 originates	 from	
Salmonella-free	sources.	
In	Denmark	 and	other	 countries,	 it	 has	been	 found	 that	 a	 reduction	 in	 the	prevalence	of	
Salmonella	amongst	pig	herds	corresponds	to	a	reduction	in	the	number	of	cases	of	human	
salmonellosis	 (Nielsen,	2001).	A	compulsory	Salmonella	 spp.	control	programme	has	been	
implemented	 since	 1995	 throughout	 the	 country	 and	 classification	 of	 national	 herds	was	
undertaken	according	to	their	NTS	status.	A	price	penalty	was	applied	to	those	farms	which	
were	 found	to	be	highly	 infected	and	pigs	 from	these	 farms	were	slaughtered	separately,	
under	increased	hygiene	precautions	(Alban,	2002).	This	incentive	for	farmers	has	helped	to	
swiftly	 increase	 the	 actions	 taken	 to	 reduce	 the	 NTS	 infection	 rate	 of	 their	 pigs	 and	 the	
result	has	seen	the	level	of	NTS	detected	in	Danish	pork	fall	 from	3.5%	in	1993	to	0.7%	in	
2000	 (Nielson,	 2001).	 	 There	 has	 been	 extremely	 encouraging	 parallel	 decline	 of	 the	
number	of	cases	of	human	salmonellosis	diagnosed	from	1,144	in	1993	to	166	in	the	year	
2000	(Nielson,	2001).	
The	 prevalence	 of	NTS	 in	 pigs	 in	 the	UK	 is	 among	 the	 highest	 in	 the	 EU,	with	 an	 in-herd	
prevalence	of	44%	(EFSA,	2009)	and	21%	prevalence	at	slaughter	(EFSA,	2008).		As	pigs	do	
not	 normally	 develop	 clinical	 signs	 of	 NTS	 infection	 (Kranker,	 2003),	 the	 bacteria	 would	
normally	 only	 be	 detected	 during	 active	 surveillance.	 	 In	 Europe	 there	 is	 no	 universal	
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protocol	for	control	as	each	pig	farm	differs	in	the	location,	management,	facilities,	host	age	
and	susceptibility.	Therefore,	biosecurity	concerns	need	to	be	continually	readdressed	at	an	
individual	 farm	 level	 to	 ensure	 that	 adequate	measures	 are	 implemented	 (Barcelo,	 1998.	
Amass,	2005a).		To	some	extent	vaccination	of	pigs	against	S.	Typhimurium	has	been	shown	
to	help	to	reduce	carriage	(de	la	Cruz,	2017),	however,	further	research	needs	to	be	carried	
out	 to	 develop	 the	 efficacy	 of	 this	 vaccination,	 and	 currently	 strict	 biosecurity	measures	
must	remain	in	place	alongside	the	implementation	of	any	vaccination	programme.		
Prevalence	amongst	pigs	in	sub-Saharan	Africa	
The	 prevalence	 of	 NTS	 in	 pigs	 has	 not	 been	 studied	 in	 detail	 in	 Kenya	 or	Malawi	 and	 a	
coordinated	 national	 epidemiological	 surveillance	 program	 for	 NTS	 is	 currently	 lacking	 in	
pigs	 in	 these	 countries	 (Kariuki,	 2006).	 	 Findings	 in	 Europe	 that	 the	 zoonotic	 strains	 of	S.	
Typhimurium	and	S.	Derby	are	the	most	common	strains	to	be	isolated	from	commercially	
produced	pigs	 lead	to	speculation	that	there	 is	high	potential	 for	zoonotic	transmission	of	
disease	 between	pigs	 and	humans	 in	 areas	where	 low-intensity,	 free-roaming	 pig	 rearing	
methods	 are	 employed.	 	 To	 investigate	 this,	 small	 studies	 have	determined	 the	presence	
and	 antimicrobial	 resistance	 profiles	 of	 NTS	 in	 pigs	 in	 South	 Africa,	 (Mathole,	 2017,	 Iwu,	
2016),	Uganda	(Ikwap,	2014),	Burkina	Faso	(Kagambèga,	2013),	Ghana	(Sekyere,	2015)	and	
Kenya	(Kariuki,	2006,	Kikuvi,	2010)	with	varying	results.			
In	 South	 Africa,	 of	 322	 porcine	 faecal	 samples	 cultured,	 5.9%	 were	 positive	 for	 NTS	
(Mathole,	 2017).	 	 The	 prevalence	 of	 NTS	 amongst	 pigs	 in	 Burkina	 Faso	was	 found	 to	 be	
slightly	higher	as	NTS	were	detected	in	the	faeces	of	16%	of	the	pigs	surveyed	(Kagambèga,	
2013).	In	relation	to	antimicrobial	resistance,	9.7%	of	S.	Typhimurium	isolates	in	pigs	from	
Ashanti,	 Ghana,	 were	 resistant	 to	 greater	 than	 three	 classes	 of	 antimicrobials	 (Sekyere,	
2015)	and	therefore	classed	as	multidrug	resistant.			
Kikuvi	 (2010)	 investigated	 the	prevalence	of	NTS	 isolated	 from	58	pigs	at	 slaughter	 in	 the	
Ndumbuini	abbatoir	in	Nairobi.		These	pigs	were	reared	in	the	Nairobi	and	Kiambu	regions	
of	 Kenya.	 	 28%	 (16/58)	 of	 these	 faecal	 samples	 cultured	 positive	 for	 NTS.	 	 Of	 these	 16	
positive	NTS	 isolates,	 11	were	 detected	 from	 carcass	 swabs	 (11/16)	 and	 five	 from	 faecal	
samples	(5/16).	The	detection	of	NTS	on	the	outside	of	the	carcases	as	well	as	in	the	faeces	
suggests	 that	 environmental	 contamination	 of	 the	 carcass	 at	 the	 abattoir	 during	
evisceration	 or	 transportation	 may	 have	 contaminated	 the	 samples,	 rather	 than	 solely	
direct	 carriage	 by	 the	 pigs	 themselves.	 	 As	 alluded	 to	 earlier,	 the	 presence	of	NTS	 in	 the	
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mesenteric	lymph	nodes	of	samples	denotes	infection	of	the	pig	during	primary	production	
rather	than	post	slaughter	during	meat	processing.			
Ikwap	 (2014)	 looked	 at	 the	 prevalence	 of	 NTS	 in	 piglets	 in	 faeces	 in	 Uganda.	 	 Sampling	
faeces	from	two	sites	it	was	found	that	the	herd	prevalence	of	NTS	was	43%	and	34%,	with	
a	 total	 herd	 prevalence	 of	 39%.	 Following	 analysis,	 20	 serovars	 were	 identified.	 The	
predominant	 serovars	 of	 NTS	 detected	 were	 S.	 Zanzibar,	 S.	 Heidelberg,	 S.	 Infantis,	 S.	
Typhimurium,	S.	Stanleyville,	S.	Aberdeen	and	S.	Kampala.	 	Risk	factors	which	appeared	to	
increase	 the	 likelihood	 of	 infection	 with	 NTS	 included	 feeding	 young	 swine	 and	 adults	
together	 rather	 than	 feeding	 separately,	 semi-intensive	 (tethering	 and	 roaming)	 versus	
intensive	management	 and	washing	 the	 feeders	daily	 rather	 than	every	other	day.	 These	
could	be	 considered	as	useful	 control	points	 for	 farms	 to	decrease	 the	 risk	of	Salmonella	
transmission	between	pigs.		
As	 demonstrated	 above,	 there	 is	 currently	 a	 great	 deal	 of	 variation	 in	 the	 published	
prevalence	of	NTS	carried	or	excreted	by	pigs	by	 in	sub-Saharan	African	countries.	 	 It	may	
be	that	this	variation	truly	reflects	different	rates	of	carriage	by	pigs	in	different	countries.	
However,	 it	 is	more	 likely	 that	 the	 lack	of	 standardisation	of	methodologies	 (in	 regard	 to	
both	 field	 and	 laboratory	work),	 sample	 size	 of	 the	 studies,	 inclusion	 of	 either	 pooled	 or	
individual	samples	used,	and	less	controllable	factors	such	as	variation	of	seasonality	during	
the	 sampling	 period,	 have	 influenced	 the	 final	 figures	 generated.	 	 For	 example,	 although	
the	bacterial	 isolation	methodologies	used	 in	Mathole	and	Kagambègas’	 studies	methods	
were	 very	 similar,	 Mathole’s	 study	 performed	 enrichment	 and	 culture	 from	 rectal	 and	
cloacal	 swabs,	 whereas	 Kagambèga	 performed	 enrichment	 of	 25g	 of	 faeces	 in	 225ml	 of	
buffered	peptone	water.	The	use	of	a	 larger	volume	of	faeces	for	the	enrichment	stage	in	
Kagambèga’s	work	may	have	contributed	to	an	increase	in	sensitivity	of	the	laboratory	work	
and	potentially	 the	higher	prevalence	of	NTS	detected	 in	porcine	 faeces.	 	 Sekyère’s	 study	
was	conducted	using	pooled	faecal	samples	from	ten	pigs,	whereas	prevalence	of	NTS	for	
the	other	studies	were	carried	out	using	results	from	individual	faecal	samples.	Additionally,	
although	 the	 laboratory	 isolation	 of	 NTS	 was	 carried	 out	 following	 the	 ISO	 6579	 (2002)	
standard	procedures	by	Ikwap	(2014)	and	Mathole	(2017),	other	authors	cited	above	used	a	
variety	of	enrichment	broths,	agars	and	tests	to	confirm	the	presence	of	NTS,	all	of	which	
will	 vary	 in	 their	 sensitivities,	 affecting	 the	 accuracy	 of	 the	 results	 produced,	 and	 the	
reliability	with	which	the	same	results	for	prevalence	could	be	generated	using	a	different	
method.		
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S.	 Typhiumurium	 and	 S.	 Enterica	 are	 the	most	widely	 reported	 zoonotic	 serovars	 of	 NTS	
which	can	be	carried	by	pigs	(FCC,	2010).	 	These	serovars	are	also	those	most	 likely	to	be	
the	causal	agent	of	invasive	NTS	disease	in	humans	in	Africa	(Gordon,	2008,	Gordon,	2001,	
Brent,	2006,	Mabey,	1987,	Kariuki,	2006,	Sigauque,	2009,	O’Dempsey,	1994,	Lepage,	1987,	
Green,	 1993).	 	 Therefore,	 the	potential	 for	 zoonotic	 transmission	 from	pigs	 to	humans	 in	
sub-Saharan	 Africa	 is	 a	 concept	 which	 needs	 further	 investigation.	 	 This	 study	 aims	 to	
provide	 information	 on	 the	 prevalence	 of	 NTS	 in	 pigs	 as	 shed	 in	 faeces	 and	 detected	 in	
mesenteric	 lymph	 nodes	 in	 Kenya	 and	 Malawi,	 providing	 information	 about	 the	 carrier	
status	and	shedding	capability	of	the	sampled	pigs.	
Epidemiology	and	risk	factors	of	NTS	disease	in	humans	
The	contribution	of	different	serovars	of	S.	enterica	to	human	disease	varies	depending	on	
the	time	and	geographical	 location	of	 infection	(Crump,	2015).	 	NTS	causes	transient,	self-
limiting	 inflammatory	 gastroenteritis	 in	 healthy	 humans	 in	 higher	 income	 countries	
(Laupland,	2010),	and	is	normally	transmitted	by	the	zoonotic	or	food-borne	route.	In	low-
middle	income	countries	(LMICs)	an	invasive	form	of	NTS	is	a	leading	cause	of	bloodstream	
infections,	 causing	 29%	 cases	 of	 septicaemia	 across	 Africa	 and	 of	 these,	 88%	 of	 the	
bloodstream	 infections	diagnosed	 in	eastern	Africa	 (Reddy,	2010,	Deen,	2012),	where	 the	
case-fatality	rate	was	20-25%	(Sigauque,	2009).	The	clinical	symptoms	in	humans	produced	
by	some	NTS	serovars	bear	a	closer	similarity	to	typhoidal	Salmonellae	serovars,	producing	
more	 invasive	 disease	 than	 others.	 	 These	 more	 invasive	 serovars	 have	 a	 differing	
epidemiology,	 clinical	manifestation	 of	 disease	 and	 illicit	 a	 different	 immune	 response	 to	
infection	than	other,	less	invasive	NTS	serovars	(Gal-Mors,	2014),	particularly	when	patients	
are	additionally	suffering	from	co-morbidities,	such	as	HIV	or	malaria.			
In	2010,	 there	were	approximately	3.4	million	 cases	of	 invasive	non-typhoidal	Salmonella	
(iNTS)	disease	worldwide,	resulting	in	an	estimated	681,316	deaths	(Ao,	2015).		This	figure	
is	likely	to	be	an	under-estimate	(Enwere,	2006),	as	poor	access	to	health-care	in	resource-
limited	 countries	 and	 lack	 of	 access	 to	 diagnostic	 tests	means	 that	 deaths	 and	morbidity	
due	to	invasive	NTS	disease	are	under-reported	(Qamar,	2015,	Rutherford,	2010).				
Non-invasive	NTS	disease	 is	 estimated	 to	 cause	 93	million	 enteric	 infections	 and	155,000	
diarrheal	 deaths	 globally	 each	 year,	 therefore	 is	 a	 major	 cause	 of	 diarrhoeal	 disease	
worldwide,	 with	 a	 proportionately	 much	 lower	 fatality	 rate	 than	 that	 of	 invasive	 NTS	
(Majowicz,	2010).	The	Global	Enterics	Multicentre	Study	(GEMS)	did	not	find	NTS	to	be	one	
of	 the	 four	major	 causes	 of	moderate-severe	 diarrhoeal	 disease	 in	 Africa	 (Kotloff,	 2013).		
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Invasive	 NTS	 does	 occur	 in	 higher	 income	 countries	 although	 at	 a	much	 lower	 incidence	
than	in	lower-middle	income	areas.		
In	 industrialised	 countries	 sources	 and	 transmission	 routes	 of	 NTS	 have	 already	 been	
extensively	 studied	 in	 humans	 and	 animals	 (Painter,	 2013)	 and	 are	 better	 understood,	
particularly	 in	 healthy	 hosts.	 In	 lower-middle	 income	 countries,	 however,	 epidemiology	
studies	 of	 NTS	 infections	 are	 extremely	 limited	 (Morpeth,	 2009)	 and	 transmission	 routes	
are	understood	to	a	far	lesser	degree	(Feasey,	2012).				
NTS	 is	 an	 important	 cause	 of	 invasive	 bloodstream	 infection	 in	 patients	 in	 sub-Saharan	
Africa	 (sSA),	 particularly	 amongst	 the	 very	 young	 (less	 than	 two	 years	 but	 older	 than	 six	
months),	 the	 elderly,	 immunocompromised,	 or	 those	 suffering	 from	 concurrent	 illnesses	
such	as	malaria,	HIV	or	malnutrition	(Feasey,	2010,	Vugia,	2004,	Varma,	2005,	Crump,	2011,	
Parry,	2013).		Elderly	people	may	have	a	higher	risk	of	developing	invasive	NTS	due	to	the	
presence	of	co-morbidities	which	weaken	the	immune	system,	for	example	renal	disease	or	
diabetes	(Crump,	2015).		Unlike	enteric	fever	in	developed	countries,	NTS	in	sSA	appears	to	
be	associated	with	many	immunocompromising	conditions	(Gordon,	2008).		As	well	as	HIV,	
this	 also	 includes	 disorders	 of	 oxidative	 cellular	 killing,	 including	 chronic	 granulomatous	
disease.	 	 In	 patients	 with	 this	 chronic	 condition	 NTS	 has	 been	 described	 as	 the	 most	
common	cause	of	bloodstream	infections	and	the	third	leading	cause	of	all	 infections	(van	
den	Berg,	2009).		
Invasive	NTS	disease	has	the	potential	to	be	caused	by	hundreds	of	serovars	of	NTS,	which	
have	varying	degrees	of	virulence	 (Jones,	2008).	 	Patients	are	 likely	 to	present	 to	hospital	
with	 a	 non-specific	 febrile	 illness	 (Gordon,	 2002,	 Peters,	 2004,	 Graham,	 2009),	 therefore	
diagnostic	 tests	 such	 as	 blood	 culture	 are	 required	 in	 order	 for	 tailored	 treatment	 to	 be	
prescribed.		Unfortunately,	this	diagnostic	test	can	be	difficult	to	implement,	particularly	in	
resource-limited	settings	(Gordon,	2011).	
The	NTS	 serovars	S.	Typhimurium	and	 Enteritidis	 are	 the	 commonest	 serovars	 associated	
with	invasive	NTS	disease	in	sSA.	For	20-50%	of	infected	children	and	adults	suffering	from	
invasive	 NTS,	 the	 clinical	 sign	 of	 diarrhoea	 may	 be	 minimal	 or	 absent	 (Gordon,	 2002,	
Feasey,	2012),	unlike	the	non-invasive	disease	of	developed	countries.	Gordon	(2008)	found	
that	75%	of	cases	of	NTS	bacteriaemia	in	Malawi	were	caused	by	S.	Typhimurium	and	21%	
were	 caused	 by	 S.	 Enteritidis,	 and	 a	 systematic	 review	 undertaken	 by	 Reddy	 (2010)	
demonstrated	that	65%	of	NTS	 infections	were	due	to	S.	Typhimurium	and	33%	due	to	S.	
Enteritidis.		
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A	 significant	difference	has	been	 found	 in	 the	age	at	which	 the	different	genders	acquire	
invasive	 NTS,	 as	 women	 have	 been	 found	 on	 average	 to	 acquire	 the	 disease	 five	 years	
earlier	 than	 men	 (Feasey,	 2010).	 HIV	 is	 a	 significant	 risk	 factor	 for	 the	 development	 of	
invasive	NTS,	 therefore	 this	 age	 disparity	 between	 the	 sexes	may	 also	 correlate	with	 the	
younger	age	of	acquisition	of	the	HIV	within	the	female	population.		
It	 had	 initially	 been	 reported	 that	 isolates	 of	 invasive	 NTS	 from	 Kenya	 and	 NTS	 causing	
gastroenteritis	 in	 developing	 countries	 shared	 similar	 serotype,	 genotype	 and	 antibiotic	
susceptibility	patterns	(Kariuki,	2006).	However,	Kingsley	first	described	the	novel	pathovar,	
multidrug	resistant	multilocus	sequence	type	ST313	(strain	number	D23580)	in	2009,	during	
the	 HIV	 pandemic,	 which	 he	 had	 discovered	 using	 multilocus	 sequence	 typing.	 	 This	
sequence	type	has	a	unique	prophage	repertoire	and	a	degraded	genome	which	does	show	
some	convergence	with	S.	Typhi	 (Kingsley,	2009).	 	Most	serovars	 isolated	from	humans	 in	
Africa	suffering	 from	 invasive	NTS	have	the	sequence	type	ST313.	This	sequence	type	has	
currently	 been	 found	 to	 be	 restricted	 to	 the	 African	 continent	 and	 appears,	 based	 on	
current	evidence,	to	be	host-adapted	to	cause	invasive	disease	in	humans	(Kingsley,	2009).	
Work	 has	 been	 undertaken	 to	 determine	 the	mechanism	 by	 which	 this	 pathovar	 causes	
invasive	 disease.	 	 One	 possible	 virulence	 gene	 has	 been	 found,	 ST313td,	 described	 in	 S.	
Typhimurium	 ST313	 and	 also	 found	 in	 other	NTS	 serovars,	 including	 S.	 Dublin	 (Herrero-
Fresno,	2014),	although	the	function	of	this	virulence	gene	is	currently	unknown.	Ongoing	
studies	 are	 continuing	 to	 elucidate	 further	 virulence	 genes;	 currently	 no	 other	 candidate	
virulence	 genes	 have	 been	 isolated	 from	 invasive	 NTS	 strains	 from	 HIV-infected	 patients	
(Preziosi,	2012).	 	Hammarlöf	 (2018)	has	detected	a	single	SNP	difference	 in	the	gene	pgtE	
found	in	a	non-coding	region	of	the	S.	Typhimurium	ST313	D23580	genome,	in	comparison	
to	 S.	 Typhimurium	 ST19	 4/74.	 This	 gene	 is	 part	 of	 a	 promotor	 region	 of	 the	 pgtE	 gene,	
which	codes	 the	protein	PgtE,	a	virulence	 factor	of	S.	Typhimurium	ST313.	 	This	virulence	
factor	 is	 linked	 to	 the	 increased	 degradation	 of	 factor	 B	 of	 human	 complement,	 so	
contributing	 to	 serum	 resistance,	 promoting	 bacterial	 survival	 and	 dissemination.	 Okoro	
(2012)	 discovered	 that	 two	 phylogenetic	 lineages	 of	 S.	 Typhimurium	 ST313	were	 distinct	
from	other	S.	Typhimurium,	in	that	they	contained	genomic	degradation	with	similarities	to	
S.	Typhi	and	the	deletions	and	pseudogenes.	These	two	lineages	of	S.	Typhimurium	ST313	
have	 the	 potential	 to	 cause	 invasive	 disease	 in	 humans	 in	 sub-Saharan	 Africa,	 and	 both	
appear	to	carry	genetic	determinants	for	multi-drug	resistance.	Analysis	has	revealed	that	
these	 two	 lineages	 developed	 separately,	 in	 close	 association	 with	 the	 HIV	 pandemic.	 A	
zoonotic	source	has	not	yet	been	identified,	therefore	it	has	been	suggested	that	they	have	
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developed	 to	be	host-adapted	 to	humans,	 and	 transmitted,	 at	 least	 partly,	 by	 human-to-
human	transmission	(Okoro,	2015).		
S.	 Typhimurium	 ST19	 is	 non-invasive	 and	 more	 commonly	 found	 to	 be	 the	 cause	 of	
diarrhoeal	 disease	 in	 humans	 in	 developed	 countries.	 	 The	 previously	 described	 invasive	
sequence	type	ST313	has	been	found	to	be	genetically	distinct	from	ST19,	containing	many	
pseudogenes	and	deletions.	Therefore,	 it	 appears	 that	 two	distinct	 clades	of	 invasive	and	
non-invasive	S.	Typhimurium	have	emerged	across	sub-Saharan	Africa	(Feasey,	2016).		
Most	commonly,	invasive	NTS	occurs	in	children	aged	2-3	years	and	is	relatively	uncommon	
in	children	between	1-4	months	of	age	 (MacLennan,	2008).	The	case	 fatality	 ratio	among	
cohorts	of	children	with	invasive	NTS	has	been	found	to	be	20-28%,	which	is	comparable	to	
the	 case	 fatality	 ratio	 of	 other	 bloodstream	 infections	 (Brent,	 2006,	 Berkley,	 2005).		
Younger,	 breastfeeding	 children	 gain	 protection	 from	 the	 transfer	 of	 passive	 immunity	 in	
the	milk	or	 the	 transplacental	 transfer	of	protective	 IgG,	 therefore	antibody	protection	 is	
likely	 important	 for	control	of	NTS	disease	 in	children	(MacLennan,	2008,	Nyirenda,	2014,	
Gondwe,	 2010).	 Despite	 this,	 invasive	 NTS	 was	 still	 found	 to	 be	 an	 important	 cause	 of	
neonatal	sepsis	in	Africa	(Milledge,	2005),	with	a	62%	mortality	rate	in	neonates	(0-30	days)	
presenting	to	the	Queen	Elizabeth	Central	Hospital,	Blantyre,	Malawi	between	1996-2001.	
In	 Kilifi,	 Kenya,	 Talbert	 (2010)	 described	 invasive	NTS	 accounting	 for	 5%	of	 blood	 culture	
isolates	and	10%	of	cerebrospinal	fluid	 isolates	amongst	4467	children	aged	0-60	days	old	
born	outside	the	hospital.		No	invasive	NTS	was	identified	from	over	2000	children	born	in	
the	hospital.	 This	 suggests	 that	 the	domestic	environment	may	have	a	 role	 to	play	 in	 the	
transmission	in	invasive	NTS	in	this	area	of	Kenya.		
As	 in	 adults,	 concurrent	 illnesses	 such	 as	 malaria,	 HIV,	 and	 malnutrition	 predispose	 to	
invasive	NTS	in	children	in	developing	countries	(Feasey,	2012).	It	has	also	been	found	that	
children	 who	 are	 homozygous	 for	 sickle	 cell	 disease	 trait	 are	 also	 susceptible	 to	 NTS	
infections	 (Sommet,	 2013).	 	 Other	 inherited	 diseases,	 such	 as	 cytokine	 deficiencies,	 in	
particular	 IL-12	 and	 IL-23,	which	 are	 important	 to	mediate	 intracellular	 killing,	 have	been	
found	to	be	associated	with	invasive	NTS	disease	(MacLennan,	2004).		
Overwhelming	evidence	has	shown	that	cases	of	invasive	NTS	in	adults	are	associated	with	
concurrent	HIV	 infection	and	advanced	HIV	disease,	with	95%	of	NTS	 infected	patients	 in	
some	 studies	 infected	with	HIV	 (Gordon,	 2002,	Watera,	 2004,	 Profeta,	 1985,	 Kankwatira,	
2004).	 	 In	children,	HIV	 is	also	a	 risk	 factor	 for	 the	development	of	 invasive	NTS	 (Berkley,	
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2005)	 and	Brent	 (2006)	 found	 that	 20%	of	 a	 cohort	 of	African	 children	with	 invasive	NTS	
were	likely	to	be	infected	with	HIV.	
During	 HIV	 infection,	 Gordon	 (2010)	 found	 that	 NTS	 establishes	 an	 intracellular	 niche.		
Several	 specific	 immune	 defects	 were	 found	 to	 be	 associated	 with	 the	 development	 of	
recurrent	episodes	of	NTS	 in	HIV	 infected	adults.	 	Loss	of	 IL-17	producing	CD4	cells	 in	 the	
gut	mucosa	 (Raffatellu,	 2008)	 permits	 rapid	 invasion,	 dysregulating	 excess	 production	 of	
anti-LPS	IgG	which	acts	to	inhibit	the	serum	killing	of	extracellular	NTS	(MacLennan,	2010,	
Trebicka,	2014).	 	The	intracellular	niche	of	NTS	in	HIV	infected	patients	is	 likely	due	to	the	
bacteria’s	 ability	 to	be	 taken	 into	 the	 cells	 before	 serum	killing	 can	occur	 (Siggins,	 2014).		
Once	 NTS	 is	 within	 the	 cells	 it	 is	 able	 to	 survive	 as	 there	 is	 a	 reduction	 in	 the	 pro-
inflammatory	 cytokine	 response	 in	HIV	 infected	 patients	 (Gordon,	 2010,	 Schreiber,	 2011,	
Gordon,	2007).	Over	time	this	leads	to	recurrence	of	NTS	disease	in	HIV	infected	individuals	
with	 mostly	 identical	 strains	 of	 NTS,	 which	 have	 been	 identified	 by	 whole	 genome	
sequencing	 (Gordon,	2002,	Okoro,	2012).	 	Recurrence	or	 recrudescence	of	NTS	disease	 in	
previously	 treated	 adults	 occurs	 in	 20-30%	 adults	 with	 HIV,	 usually	 after	 a	 period	 of	 4-6	
months	 (Gordon,	 2010).	 	 Infection	 with	 a	 new	 strain	 has	 only	 been	 found	 in	 20%	 of	
recurrent	cases	of	adults	with	HIV	(Gordon,	2002,	Okoro,	2012).		Acquisition	of	new	strains	
of	NTS	in	these	adults	may	also	be	postulated	to	occur	due	to	human-to-human	faeco-oral	
transmission	of	invasive	NTS,	as	NTS	has	been	found	to	be	shed	in	human	faeces.		
The	risk	of	NTS	to	patients	with	HIV	has	been	found	to	decrease	significantly	 in	the	era	of	
anti-retroviral	drug	therapy	(Hung,	2007),	although	isolates	from	HIV	patients	infected	with	
invasive	 NTS	 have	 been	 found	 to	 be	 increasingly	 resistant	 to	 fluoroquinolones.	 	 Once	
effective	anti-retroviral	drug	 treatment	has	been	established,	 recurrence	of	NTS	 infection	
appears	to	be	less	common	(Hung,	2007).	
In	 the	 early	 HIV	 epidemic,	 mortality	 due	 to	 concurrent	 NTS	 and	 HIV	 was	 found	 by	 Gilks	
(1990)	 and	 Gordon	 (2002)	 to	 be	 50%	 in	 sSA.	 Since	 the	 improvement	 in	 recognition	 and	
management	 of	 NTS	 in	 this	 area,	 and	 potentially	 the	 use	 of	more	 effective	 antimicrobial	
treatments	 and	 antiretroviral	 therapy,	 mortality	 rates	 appear	 to	 have	 fallen	 to	 20-25%	
(Gordon,	2008,	Arthur,	2001,	Feasey,	2014).		
A	relationship	has	been	identified	between	invasive	NTS	and	malaria	affecting	both	children	
and	adults,	initially	in	West	Africa	(Mabey,	1987),	particularly	in	patients	affected	by	severe	
malarial	anaemia	(Bronzan,	2007),	severe	acute	malaria	(Berkley,	2009)	and	recent	malaria	
(Brent,	2006).	 	Cerebral	malaria	has	not	been	found	to	be	associated	with	increased	cases	
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of	NTS	 (Bonzan,	 2007).	 Children	with	 invasive	NTS	 have	 been	 found	 to	 be	more	 likely	 to	
have	 received	 recent	 treatment	 for	 malaria,	 and	 have	 concurrent	 anaemia,	 jaundice	 or	
hypoglycaemia,	which	can	be	 interpreted	as	complications	of	malaria.	 	 	Mackenzie	 (2010)	
found	a	 temporal	 reduction	 in	 cases	of	NTS	amongst	 children	when	 reduction	of	malarial	
cases	was	documented	in	the	Gambia.		A	temporal	relationship	has	also	been	documented	
by	 Tabu	 (2012),	 Mtove	 (2011)	 and	 Biggs	 (2014).	 	 Tabu	 (2012)	 also	 found	 a	 spatial	
relationship	 between	 malaria	 and	 NTS	 incidence,	 contrasting	 high-	 and	 low-	 incidence	
regions.		
This	association	between	malaria	and	invasive	NTS	disease	may	not	be	specific	for	NTS,	as	
the	 incidence	 of	 all	 bacteraemias	 has	 been	 found	 to	 be	 higher	 in	 children	 concurrently	
infected	by	malaria	(Scott,	2011).		
Malnutrition	is	associated	with	invasive	NTS	in	African	children	(Brent,	2006).	Berkley,	2005	
found	this	association	in	children,	with	an	odds	ratio	of	1.68	(95%	confidence	interval,	1.15	
to	2.44)	in	rural	Kenya.	
Invasive	NTS	has	been	found	to	show	a	strongly	seasonal	infection	rate	amongst	both	adults	
and	children,	coinciding	with	the	rainy	season	(Gordon,	2008).	This	may	reflect	a	number	of	
factors	which	occur	during	 this	 season:	waterborne	 transmission	of	 the	disease,	 seasonal	
malaria	 transmission	 during	 periods	 of	 increased	 rainfall	 also	 increasing	 the	 likelihood	 of	
developing	concurrent	NTS,	associated	food	scarcity	and	malnutrition,	or	a	combination	of	
these	factors.	Further	investigations	need	to	be	conducted.		
Diagnosis	of	NTS	in	humans	
The	gold	standard	 for	diagnosis	of	 invasive	NTS	 in	humans	 is	blood	culture,	bone	marrow	
sample	or	stool	culture	examination,	which	are	all	techniques	that	require	some	expertise,	
time	 and	 diagnostic	 capabilities	 to	 perform	 and	 analyse	 the	 results	 effectively	 (Gordon,	
2011).	 	 It	 is	 not	 possible	 to	 presumptively	 diagnose	 invasive	 NTS	 by	 clinical	 examination	
alone	 either	 in	 children	 or	 adults,	 so	 there	 is	 an	 urgent	 need	 for	 rapid	 and	 affordable	
diagnostic	tools	(Nadim,	2010,	Graham,	2009,	Gordon,	2002,	Peters,	2004).	
A	 polymerase	 chain	 reaction	 (PCR)	 assay	 has	 recently	 been	 trialled	 for	 epidemiological	
surveillance	 of	 invasive	 NTS	 from	 stool	 samples	 of	 children	 suffering	 from	 diarrhoea	
(Cunningham,	 2010,	 Lin,	 2010),	 and	 a	multiplex	 PCR	has	 been	described	 that	 can	 reliably	
identify	the	most	common	typhoidal	and	non-typhoidal	Salmonella	causing	invasive	disease	
in	West	Africa	(Tennant,	2010).		However,	as	the	concentration	of	invasive	NTS	in	blood	has	
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been	shown	to	be	as	low	as	1	cfu/ml	in	patients	with	clinical	signs	(Gordon,	2010),	it	seems	
less	 likely	 that	PCR	will	 be	as	 sensitive	as	a	 rapid	diagnostic	 test,	without	pre-enrichment	
occurring	first.	Further	research	needs	to	be	carried	out	in	this	area.		
Treatment	Considerations	of	NTS	in	humans	
Antimicrobial	agents	are	not	recommended	for	treatment	of	non-severe,	NTS	diarrhoea	in	
healthy	 adults	 or	 children,	 but	 are	 recommended	 for	 people	 with	 evidence	 of	 sepsis	 or	
extra-intestinal	 infection	 or	 for	 specific	 populations	 at	 risk	 for	 bacteraemia	 and	
disseminated	disease	(Crump,	2015).	
Invasive	NTS	has	also	been	shown	to	establish	an	intracellular	niche	in	the	blood	and	bone	
marrow	 (Gordon,	 2010).	 Therefore,	 effective	 treatment	 depends	 on	 the	 ability	 of	
antimicrobials	 to	 penetrate	 intracellular	 sites	 of	 infection	 in	 the	 macrophages	 of	 the	
reticuloendothelial	system	and	gallbladder.	Some	antimicrobials,	 including	gentamicin	and	
first-	and	second-generation	cephalosporins	such	as	cefuroxime,	appear	 to	be	effective	 in	
vitro	but	can	be	ineffective	in	vivo	(Kariuki,	2015,	Feasey,	2015).	
For	 invasive	 NTS	 there	 is	 only	 very	 limited	 historical	 experience	 of	 the	 use	 of	
chloramphenicol	 compared	 to	 the	 fluoroquinolone,	 ciprofloxacin.	 Ciprofloxacin	 was	
introduced	 to	 the	 advised	 treatment	 regime	 following	 the	 emergence	 of	 resistance	 to	
chloramphenicol	 (Gordon,	 2008)	 in	 treatment	 of	 invasive	 NTS	 in	 Africa.	 The	 reported	
recurrence	ratio	after	treatment	with	chloramphenicol	was	43%	(Gordon,	2002),	compared	
to	 30%	 following	 treatment	 with	 ciprofloxacin	 (Gordon,	 2010).	 This	 difference	 might	 be	
attributable	to	improved	intracellular	penetration	of	the	fluoroquinolone.	The	case	fatality	
ratio	also	fell	gradually	over	the	reported	period,	but	this	could	be	attributable	to	multiple	
effects	other	than	the	change	in	antimicrobial	use	(Gordon,	2008).	
In	 low	resource	settings,	commonly	used	antimicrobials	are	usually	easily	available	to	buy	
without	 prescription	 in	 pharmacies	 and	 shops	 and	 counterfeit	 or	 substandard	 antibiotics	
are	also	often	commonly	for	sale	(Caudron,	2008).	In	these	countries,	where	the	diagnosis	
of	NTS	is	likely	to	be	unconfirmed	prior	to	therapy,	only	sporadic	treatment	may	be	given,	
which	 can	 lead	 to	 the	 recrudescence	 or	 development	 of	 antimicrobial	 resistance.	 	 The	
detection	 and	monitoring	 of	 chronic	 carriage	 of	 NTS	 is	 vital	 to	 public	 health,	 particularly	
considering	the	widespread	drug	resistance	of	NTS.	
There	 is	 little	 research	 evidence	 to	 investigate	 the	optimal	 treatment	 regime	 for	 invasive	
NTS	 disease.	 	 It	 would	 be	 particularly	 important	 to	 investigate	 the	 effects	 of	 treatment	
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following	initiation	of	anti-retroviral	therapy	in	patients	with	HIV	who	contract	with	invasive	
NTS.	Further	 study,	 ideally	 in	 the	 form	of	multicentre	 randomised	controlled	 trials,	would	
be	extremely	useful	(Crump,	2015).	
Zoonotic	transmission	of	NTS		
Currently,	 in	sSA,	small	molecular	studies	of	NTS	isolated	from	humans	and	animals	in	the	
same	environment	have	failed	to	find	similarities	between	strains.	Family	members	of	sick	
humans	have	been	found	to	carry	more	closely	related	strains	(Kariuki,	2006,	Kariuki,	2002)	
than	 animals	 or	 the	 environment.	 Therefore,	 it	 was	 hypothesized	 that	 S.	 Typhimurium	
ST313	 had	 a	 reduced	 host	 range	 and	 infection	was	 exclusively	 restricted	 to	 human	hosts	
rather	 than	any	other	 species	 (Kariuki,	 2006).	 	However,	S.	Typhimurium	ST313	has	been	
found	 to	 have	 the	 ability	 to	 cause	 invasive	disease	 in	 chickens	 (Parsons,	 2013),	 and	mice	
(Herrero-Fresno,	 2014,	 Yang,	 2015)	 offering	 the	 suggestion	 that	 zoonotic	 spread	 to	 some	
degree	may	be	a	potential	route	of	transmission.	
Asymptomatic	 carriage	 of	 NTS	 by	 humans	 occurs	 fairly	 commonly	 (Kariuki,	 2006,	 Kotloff,	
2013),	 although	 the	 contribution	 that	 asymptomatic	 carriage	 plays	 in	 the	 transmission	 of	
NTS,	particularly	ST313,	between	humans	is	currently	unclear.	The	diversity	of	NTS	isolated	
from	enteric	 samples	 is	 likely	 to	be	wide	 (Paglietti,	2013)	and	 it	 is	 likely	 that	 some	of	 the	
NTS	bacteria	found	have	the	potential	for	pathogenicity	in	some	species.	
Risk	of	transmission	of	NTS	to	humans	in	the	slaughterhouse	environment	
Although	 there	 is	 currently	 no	 confirmatory	 evidence	 that	 S.	 Typhimurium	 ST313	 is	
transmitted	 by	 animals	 to	 cause	 invasive	 disease	 in	 humans,	 other	 sequence	 types	 of	 S.	
Typhimurium	 and	 serovars	 of	 Salmonella	 have	 the	 potential	 to	 cause	 gastrointestinal	
disease	following	faeco-oral	transmission.		Meat	destined	for	human	consumption	which	is	
contaminated	 with	 faecal	 material	 at	 the	 slaughterhouse	 during	 carcass	 processing,	
provides	 an	 opportunity	 for	 NTS	 transmission	 to	 occur	 both	 to	 consumers	 ingesting	 the	
meat,	 and	 also	 to	 abattoir	 workers	 in	 the	 slaughterhouse	 environment,	 especially	 if	 the	
workers’	 hygiene	 standards	 and	 the	 availability	 of	 personal	 protective	 equipment	 are	
lacking.	 	 The	 meat	 processing	 industry	 differs	 between	 countries;	 in	 LMICs	 slaughter	
facilities	vary	from	large	 industrial	meat	processing	plants	to	unregulated	facilities	 in	rural	
areas	(Clottey,	1985).		Often,	in	areas	where	the	process	is	unregulated,	there	will	also	be	a	
lack	 of	 suitable	 or	 affordable	 materials	 for	 the	 processing	 and	 transportation	 of	 meat	
(Mann,	1984).	These	factors,	in	combination	with	the	lack	of	education	and	understanding	
of	the	risk	of	transmission	of	 food	bourne	disease,	means	that	hygiene	conditions	 in	rural	
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slaughterhouses	 in	 LMICs	 are	 often	 poor	 (Mann,	 1984,	 FAO,	 2010),	 offering	 a	 greater	
opportunity	for	faeco-oral	transmission	to	occur.		
Hazard	 Analysis	 and	 Critical	 Control	 Point	 (HACCP)	 is	 the	 name	 for	 a	 systematic,	
preventative	 approach	 to	 food	 safety	 developed	 in	 the	 1950s	 by	 the	 Pillsbury	 Company,	
USA.	 In	HMICs,	HACCP	programs	are	regularly	 in	place	at	all	stages	of	the	food	processing	
chain	and	these	stages	are	regulated	by	official	bodies.	In	Kenya	and	Malawi,	particularly	in	
the	 rural	 communities,	 there	 are	numerous	 failings	present	during	 the	 slaughter	process,	
which	 would	 ideally	 be	more	 strictly	 regulated	 as	 part	 of	 the	 HACCP	 programme.	 These	
include	 inadequate	 infrastructure,	poor	hygiene,	 lack	of	ante	and	post	mortem	 inspection	
and	inadequate	training	of	slaughterhouse	workers	(FAO,	2010,	Herenda,	1994).	As	well	as	
increasing	the	risk	of	contamination	of	the	meat	with	microbes	prior	to	entry	into	the	food	
chain;	 this	 lack	 of	 infrastructure	 at	 the	 level	 of	 the	 slaughterhouse	 also	 endangers	 the	
health	 of	 any	 slaughterhouse	 workers	 or	 others	 handling	 the	 raw	 carcasses	 due	 to	 the	
increased	potential	for	transmission	of	zoonotic	food	borne	disease.			
There	 are	 seven	 main	 principles	 of	 HACCP.	 	 The	 overall	 aims	 are	 to	 identify	 risks	 and	
hazards	 in	 the	 food	 processing	 pathway	 as	 well	 as	 critical	 control	 points	 where	 these	
hazards	can	potentially	be	controlled;	establish	critical	limits	for	each	of	the	critical	control	
points,	such	as	bacterial	 load	of	meat	or	water	temperature;	and	creation	of	a	monitoring	
plan,	 followed	 by	 detailing	 corrective	 actions	 that	 should	 be	 taken	 should	 the	 levels	 of	
critical	control	points	deviate,	followed	by	establishing	a	system	for	ongoing	monitoring	and	
record	keeping.			
It	is	expected	that	in	the	more	urban	slaughterhouses	in	Nairobi,	with	a	higher	throughput	
of	animals	with	meat	supplied	to	outlets	all	over	Kenya,	that	the	HACCP	steps	will	be	more	
firmly	 regimented,	 records	will	 be	 kept	 of	 post	 and	 ante-mortem	 inspection	 and	 training	
offered	to	the	staff	to	facilitate	the	hygienic	handling	of	meat.	In	the	rural	slaughterhouses	
of	Kenya	and	Malawi,	 it	 is	anticipated	that	the	steps	to	monitor	the	critical	control	points	
will	not	be	 in	place.	 In	 fact,	Cook	 (2017)	 found	 that	protective	clothing	was	only	worn	by	
55%	 of	 workers	 in	 slaughterhouses	 and	 only	 35%	 of	 the	 buildings	 had	 hand	 washing	
facilities	 in	 place.	 	 The	 purpose	 of	 protective	 clothing	 is	 primarily	 to	 protect	 the	 meat	
product	from	contamination,	and	also	to	protect	handlers	of	the	meat	from	zoonoses	that	
can	 be	 transmitted	 directly,	 such	 as	 leptospirosis	 and	 brucellosis.	 	 In	 all	 rural	
slaughterhouses	surveyed	in	Western	Kenya,	Cook	(2017)	found	that	slaughtering,	bleeding,	
skinning	 and	 evisceration	 were	 performed	 in	 the	 same	 area	 of	 the	 slaughterhouse,	 a	
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procedure	known	as	‘batch	slaughtering’.	Ideally,	a	HACCP	control	point	would	represent	a	
division	in	the	slaughterhouse	between	the	dirty’	(killing,	bleeding)	and	‘clean’	(evisceration	
and	 splitting)	 operations	 to	 prevent	 contamination	 of	 the	 carcass.	 (Codex-Alimentarius-
Commission,	 2005).	 Cook	 (2017)	 also	 found	 that	 the	majority	 of	 carcass	 processing	 took	
place	 on	 the	 ground,	 a	 HACCP	 which	 would	 be	 controlled	 by	 regulation	 in	 areas	 where	
stricter	 control	 is	 placed	 over	 the	 steps	 of	 the	 slaughtering	 process.	 It	 is	 stated	 by	
international	 guidelines	 that	 hot	 and	 cold	 water	 should	 be	 available	 for	 cleaning	 the	
equipment	 and	workers’	 hands,	 along	with	 soap	 (Codex-Alimentarius-Commission,	 2005).	
Considering	this	as	a	HACCP,	it	is	not	expected	that	this	facility	will	be	available	in	the	more	
rural	areas.	Hand	washing	plays	a	role	in	protecting	the	slaughterhouse	workers	against	the	
direct	 transmission	 of	 bacterial	 pathogens,	 as	 well	 as	 decreasing	 the	 risk	 of	 meat	
contamination.		
In	Kenya,	the	meat	industry	is	regulated	by	the	directorate	of	Veterinary	Services	under	the	
State	Department	of	Livestock	 in	the	Ministry	of	Agriculture,	Livestock	and	Fisheries	(Gov.	
of	 Kenya,	 2012).	 In	2012,	 a	 revised	Meat	Control	Act	was	put	 in	place	was	 introduced	 to	
standardise	 the	 meat	 industry	 across	 the	 country.	 The	 components	 of	 this	 revised	 Act	
covers	 building	 layout,	 personal	 hygiene,	 carcass	 handling,	waste	management	 and	meat	
inspection.	 The	 Meat	 and	 Meat	 Products	 Act	 of	 Malawi	 was	 released	 in	 1975	 provides	
standards	for	the	Meat	Industry	in	the	country	to	follow.	This	Act	has	not	yet	been	revised	
since	this	time.	
Consumers,	as	well	as	slaughterhouse	workers,	are	also	at	risk	from	meat	which	has	been	
faeco-orally	 contaminated	 during	 the	 slaughtering	 and	 carcass-dressing	 process.	 In	more	
rural	 areas	 of	 Kenya	 and	 Malawi,	 pork	 is	 often	 cooked	 slowly	 over	 a	 flame	 with	 no	
temperature	regulation.	The	meat	is	normally	heated	for	a	long	time	until	it	is	bought	by	a	
consumer,	and	the	variability	in	the	length	of	time	of	cooking	can	determine	whether	or	not	
any	microbes	 contaminating	 the	 surface	 of	 the	meat	 from	 the	 slaughterhouse	 are	 killed.	
Should	 the	 temperature	 be	 low,	 or	 the	 meat	 cooked	 for	 an	 inadequate	 length	 of	 time,	
microbes	may	survive	and	act	as	a	source	of	food	borne	zoonotic	infection.		
Antibiotic	resistance	mechanisms	of	NTS	
It	has	been	found	that	recent	use	of	antimicrobials	may	facilitate	NTS	infection	in	humans	
(Delarocque-Astagneau,	 2000).	 	 There	 has	 been	widespread	 use	 of	 antimicrobials	 to	 halt	
disease	 caused	 by	 NTS,	 which	 has	 led	 to	 the	 development	 of	 antimicrobial	 resistance	
displayed	by	this	bacteria	worldwide	(Mathole,	2017).	
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Resistance	 to	 the	 commonly	 used	 antimicrobials	 such	 as	 ampicillin,	 chloramphenicol,	
trimethoprim-sulfamethoxazole	are	commonly	detected	on	plasmids	 (Butaye,	2006).	 	 In	a	
study	by	Makoka	 (2012),	77.4%	of	NTS	 isolates	 from	humans	were	 resistant	 to	ampicillin,	
81.5%	 to	 trimethoprim-sulfamethoxazole	 and	 71%	 to	 chloramphenicol.	 	 Ampicillin	
resistance	 of	 NTS	 is	 often	 mediated	 by	 ß-lactamases	 (blaPSE	 and	 blaTEM	 genes).	 	 Several	
mechanisms	 can	be	 associated	with	 chloramphenicol	 resistance;	 there	 are	 three	 types	 of	
chloramphenicol	 acetyltransferases	described	 in	Gram-negative	bacteria	 (CATs,	 Type	 I-III).		
The	most	 frequent	 to	be	determined	 in	Enterobactericeae	 is	 CAT	 I	 (Arcangioli,	 2000).	 	 As	
folate	 pathway	 inhibitors,	 trimethoprim	 and	 sulfamethoxazole	 are	 affected	 by	 resistance	
genes	acquired	by	bacteria,	which	have	a	role	in	the	folate	pathway	but	do	not	bind	these	
compounds.	 The	 dfr	 (dihydrofolate	 reductase)	 genes	 of	 S.	 Enterica	 encode	 trimethoprim	
resistance	 and	 the	 sul	 genes	 (sul1	 or	 sul2)	 encode	 sulfamethoxazole	 resistance	 (Glenn,	
2011).	
The	 emergence	 of	 Salmonella	 spp.	 phenotypes	 resistant	 to	 the	 quinolones,	 e.g.	
ciprofloxacin	and	nalidixic	acid,	and	the	cephalosporins,	e.g.	ceftriaxone,	has	 raised	public	
health	concerns	worldwide,	including	in	Blantyre,	Malawi,	where	extended	spectrum	beta-
lactamase	(ESBL)	and	fluoroquinolone-resistant	NTS	isolates	have	been	previously	identified	
(Gray,	 2006).	 Cephalosporins	 are	 important	 for	 treatment	 of	 invasive	 NTS,	 particularly	 in	
children,	 in	 which	 age	 group	 the	 use	 of	 fluoroquinolones	 should	 be	 avoided	 due	 to	 the	
occurrence	 of	 adverse	 side	 effects.	 ß-lactamases	 of	 the	 ESBL	 or	 AmpC	 type	 were	 first	
recorded	in	the	mid-1980s,	conferring	resistance	to	the	extended	spectrum	cephalosporins,	
and	 some	 of	 the	 earliest	 reports	 were	 from	 North	 Africa	 (Miriagou,	 2004,	 Ben	 Hassen,	
1990).		Cephalosporin	antibiotics	act	by	disrupting	bacterial	cell	wall	synthesis	by	disrupting	
the	 penicillin	 binding	 proteins	 and	 the	 cross-linking	 of	 peptidoglycan	 (Marshall,	 1999).	 ß-
lactamases	 commonly	 mediate	 resistance,	 including	 to	 the	 extended-spectrum	
cephalosporins	e.g.	These	cleave	 the	beta-lactam	ring	so	 inactivating	 the	antibiotic.	There	
are	 three	 groups	 of	 ß-lactamases	 which	 mediate	 resistance	 to	 the	 extended-spectrum	
cephalosporins:	extended	spectrum	beta-lactamases	(ESBLs),	carbapenemases,	and	AmpC-
type-	ß-lactamases	(Paterson,	2005,	Philippon,	2002).	In	Salmonella	spp.,	the	predominant	
cause	 of	 cephalosporin	 resistance	 is	 due	 to	 the	 AmpC	 plasmid-mediated	 ß-lactamases,	
cephamycinases	(CMY)	which	are	encoded	by	the	blaCMY	genes.		Resistance	due	to	ESBLs	has	
occurred	 more	 often	 in	 non-typhoidal	 than	 typhoidal	 Salmonella	 strains	 (Crump,	 2015).		
Resistance	due	to	ß-lactamase	enzymes	may	spread	horizontally	as	the	genes	involved	are	
commonly	encoded	on	mobile	genetic	elements	which	 include	plasmids,	 transposons	and	
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integrons.		Enzymes	of	CMY	and	CTX-M	types	(blaCTX-M63,	blaCTX-M14,	blaCMY-2)	have	been	noted	
in	 Salmonella	 in	 Thailand	 (Pornruandwong,	 2011,	 Sirichote,	 2010)	 and	 some	 of	 these	
isolates	 also	 demonstrate	 resistance	 to	 fluoroquinolones	 in	 humans	 (Sirichote,	 2010,	
Sirichote,	 2010,	 Kulwichit,	 2007),	 which	 is	 particularly	 worrisome	 as	 more	 expensive	 or	
difficult	 to	 obtain	 drugs	 may	 be	 required	 for	 treatment	 of	 these	 cases,	 such	 as	 the	
carbapenems	or	tigecycline.	
Fluoroquinolone	 antimicrobials	 inhibit	 bacterial	 replication	by	 affecting	 the	 enzymes	DNA	
gyrase	and	 topoisomerase	 IV.	 	 The	 subunits	of	 these	enzymes	are	encoded	by	gyrA,	gyrB	
and	 parC	 and	 parE	 genes	 (Hopkins,	 2005).	 Reduced	 susceptibility	 or	 resistance	 of	 NTS	
bacteria	 to	 fluoroquinolones	may	 be	 induced,	 dependent	 upon	 the	 number	 of	mutations	
acquired	 in	 the	 regions	 of	 these	 genes	 (Hopkins,	 2005,	 Turner,	 2006).	 	 Plasmid	mediated	
mechanisms	 have	 also	 been	 described	 to	 demonstrate	 low	 levels	 of	 resistance	 to	
fluoroquinolones	 e.g.	qnrA	which	 has	 been	detected	 in	NTS	 (Strahilevitz,	 2009,	Martinez-
Martinez,	1998).		
Genes	which	 encode	 proteins	which	 effect	 non-enzymatic	mechanisms	 of	 resistance,	 e.g.	
cmlA	and	floR,	have	also	been	detected	in	S.	Enterica	(Arcangioli,	2000,	Glenn,	2011).	
Recently,	 isolates	 with	 extensively	 multi-drug	 resistant	 phenotypes	 have	 emerged	 in	
humans.	 S.	 Typhimurium	 isolates	 resistant	 to	 12-15	 antimicrobial	 agents,	 from	 6-7	 drug	
classes	 including	the	cephems,	have	been	reported	in	Malaysia	and	Vietnam	(Tiong,	2010,	
Vo,	2010,	Benacer,	2010)	and	 isolates	resistant	to	6-7	antimicrobial	agents,	compromising	
of	3-5	drug	classes,	have	been	detected	in	Thailand	(Wannaprasat,	2011).	
A	multi-drug	resistant	phenotype	of	S.	Typhimurium	was	first	detected	in	UK	in	the	1980s,	
closely	 associated	 with	 the	 specific	 phage-type	 DT104	 (Threlfall,	 2002).	 This	 phenotype	
displays	resistance	to	 five	antimicrobial	agents;	ampicillin,	chloramphenicol,	streptomycin,	
tetracycline	 and	 sulphonamides.	 This	 resistance	 phenotype	 was	 referred	 to	 as	 ACSSut.		
Since	this	time,	although	initially	ACSSut	was	found	in	several	other	European	countries,	the	
phenotype	 prevalence	 has	 since	 declined	 (Parry,	 2003,	 Threllfall,	 2000).	 	 The	 resistance	
genes	for	this	phenotype	are	often	clustered	together	on	a	chromosomal	genetic	element	
Salmonella	Genomic	Island	1	(SGI-1).		Initially	this	element	was	detected	in	S.	Typhimurium	
DT104,	but	has	since	been	noted	in	a	variety	of	serovars	(Levings,	2005,	Doublet,	2005,	Hall,	
2010).	 To	 be	more	 exact,	 SGI-1	 is	 classically	 a	 14kb	 sequence	 bracketed	 by	 two	 integron	
structures	 containing	 the	 following	 antimicrobial	 resistance	 genes:	 blaPSE-1	 conferring	
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ampicillin	resistance,	floR;	chloramphenicol	and	florfenicol,	aadA2	to	streptomycin,	sul1	to	
sulphonamides	and	tetG	to	tetracycline	(Boyd,	2002).	
NTS	isolates	resistant	to	the	carbapenems	have	been	reported	in	China,	Columbia,	Pakistan	
and	 the	 US	 and	 variants	 displaying	 resistance	 to	 cephalosporins	 and	 carbapenems	 (KPC-	
dependent	resistance)	have	been	detected	since	2009.	The	enzyme	NDM-1	carbapenemase	
and	New	Delhi	metallo-beta-lactamase-1	(NDM-1)	enzyme	were	the	most	common	in	these	
isolates	 (Jure,	 2014,	 Rodriguez,	 2014,	 Irfan,	 2015,	 Rasheed,	 2013,	 Huang,	 2013);	
concerningly,	 these	 isolates	 were	 also	 found	 to	 be	 resistant	 to	 most	 aminoglycosides,	
trimethoprim-sulfamethoxazole	and	azithromycin	(Le	Hallo,	2013).	
One	study	of	a	commercial	pig	herd	and	one	of	smallholder	pig	 farms	 in	South	Africa	has	
been	currently	undertaken	 to	 investigate	antimicrobial	 resistance	of	NTS	carried	by	 these	
animals	in	sub-Saharan	Africa	(Iwu,	2016).	Mathole’s	more	rural	study	(2017)	found	that	of	
322	 free-range	 healthy	 pigs,	 19	 isolates	 of	 NTS	 were	 detected,	 of	 a	 diverse	 range	 of	
serotypes.	 All	 NTS	 isolates	 were	 sensitive	 to	 cefotaxime,	 enrofloxacin,	 florphenicol	 and	
polymixin	B.	Most	of	the	NTS	isolates	(66.7%)	were	resistant	to	at	 least	one	antimicrobial,	
which	 was	 predominantly	 trimethoprim,	 followed	 by	 ampicillin.	 No	 multi-drug	 resistant	
isolates	(resistant	to	three	of	more	classes	of	antibiotics)	were	detected.			
Of	 the	 commercial	 pig	 herd	 in	 Iwu’s	 study	 (2016),	 258	 presumptive	 NTS	 isolates	 were	
detected	 from	 faecal	 samples	 from	 500	 adult	 pigs,	 a	 much	 higher	 prevalence	 than	
Mathole’s	 study	 (2017).	 	 Reasons	 for	 this	 higher	 prevalence	 could	 be	 related	 to	 closer	
contact	of	the	animals	in	more	intensive	livestock	rearing	systems	than	the	less	commercial	
small-holding	 units.	 	 Forty-eight	 of	 these	 isolates	 underwent	 antimicrobial	 susceptibility	
testing	using	 the	disc	diffusion	method.	Using	PCR	with	primer	 sequences	 for	 the	blaampC,	
tetA	and	strA	genes,	the	authors	found	that	approximately	54%	of	the	isolates	were	positive	
for	 the	 blaampC	 antimicrobial	 resistance	 gene	 (further	 details	 of	 this	 gene	 were	 not	
identified),	 61%	 for	 the	 tetA	 gene	 and	 44%	 for	 the	 strA	 gene.	 16%	 of	 the	 isolates	 were	
resistant	 to	 11/18	 antibiotics	 tested,	which	 included	 third	 generation	 cephalosporins	 and	
fluoroquinolones.	All	 isolates	were	 resistant	 to	 tetracycline,	75%	 to	ampicillin	and	75%	 to	
streptomycin.	Four	of	the	resistant	isolates	demonstrated	the	previously	mentioned	gene-
encoded	 resistance	 pattern	 of	 DT104,	 ACSSut	 (ampicillin,	 chloramphenicol,	 streptomycin,	
sulphonamides	and	 tetracycline).	This	multidrug	 resistance	profile	has	been	 isolated	 from	
pigs	and	pig	products	in	several	countries	(Kishima,	2008)	and	is	one	of	two	most	common	
MDR	 patterns	 to	 be	 detected	 in	 both	 pigs	 and	 humans	 (Gebreyes,	 2009),	 and	 therefore	
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poses	a	risk	to	human	and	animal	health.		These	results	are	more	similar	to	results	observed	
in	commercial	pig	farms	in	other	parts	of	the	world,	such	as	New	Zealand	(Gebreyes,	2000)	
and	Spain	(Agustin,	2005).		Antimicrobials	are	frequently	used	as	growth	promoters	and	in	
the	 treatment	 of	 infections	 in	 South	 Africa.	 	 The	 results	 of	 this	 study	 show	 that	
antimicrobial	 resistance	 is	 a	 concern	 in	 countries	 in	 sub-Saharan	 Africa.	 Although	
commercial	pig	production	may	confer	a	greater	risk	of	multi-drug	resistance,	likely	due	to	
overuse	 of	 antimicrobials	 as	 growth	 promotors	 and	 potentially	 prophylactically	 to	 treat	
disease,	further	investigation	needs	to	be	undertaken	on	this	continent.				
Preventing	NTS	disease	in	humans	and	pigs	
It	 is	 hoped	 that	 in	 the	 future	 a	 safe,	 efficacious	 and	 reasonable	 priced	 vaccine	 will	 be	
developed	 to	 prevent	 invasive	 NTS	 infection	 of	 both	 pigs	 and	 humans.	 	 Salmonellae	 are	
facultative	 intracellular	 bacteria,	 therefore	 a	 live	 attenuated	 vaccine,	 which	 stimulates	 a	
cell-mediated	immune	response	is	necessary	to	offer	protection	against	clinical	disease	and	
intestinal	 colonisation	 in	both	 species.	However,	 the	 common	occurrence	of	 invasive	NTS	
disease	 in	 already	 immunocompromised	 human	 patients	 presents	 a	 challenge	 for	 the	
development	of	an	effective	vaccine.			
	Currently,	efforts	are	underway	to	evaluate	the	development	of	a	few	candidate	vaccines	
for	 humans	 and	 any	 introduction	 of	 a	 vaccine	 is	 likely	 to	 be	 some	 time	 in	 the	 future	
(MacLennan,	2014,	Martin,	2014).		The	role	of	antibody	in	serum	and	intracellular	oxidative	
killing	 of	 invasive	 NTS	 in	 African	 children	 has	 been	 postulated	 as	 a	 potential	 important	
target	 for	 vaccine	 development	 (MacLennan,	 2008,	 Tennant,	 2010).	 	 There	 are	 currently	
vaccines	available	to	counter	NTS	in	poultry	and	livestock,	but	no	NTS	vaccines	are	available	
for	humans.			
Pigs	may	 be	 vaccinated	 against	NTS	 to	 fulfil	 at	 least	 one	 of	 two	 aims;	 to	 gain	 protection	
from	 clinical	 disease	 or	 to	 reduce	 the	 degree	 of	 subclinical	 shedding	 of	 NTS	 bacteria.		
Control	 of	 the	 specific	 serovars	 causing	 clinical	 disease	 may	 require	 the	 use	 of	 a	 killed	
vaccine	prepared	to	provide	protection	to	naïve	pigs	during	a	specific	outbreak,	in	addition	
to	 other	 more	 biosecurity-focussed	 control	 measures	 including	 movement	 restriction.		
Vaccination	 to	 reduce	 subclinical	 shedding	 of	 NTS	 by	 pigs	 in	 faeces	 in	 the	 context	 of	
continuous	herd	reinfection	requires	vaccination	against	a	number	of	serovars,	which	may	
originate	 from	 different	 antigenic	 groups.	 S.	 Typhimurium	 shows	 a	 different	 pattern	 of	
invasion,	multiplication	and	spread	than	S.	Cholerasuis	(Boyen,	2008)	and	protection	from	
subclinical	shedding	of	both	serovars	would	involve	two	different	antibody	stimulants	to	be	
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present	 in	 the	 vaccination.	 	 Routine	 herd	 monitoring	 for	 NTS	 is	 often	 carried	 out	 by	
serological	 testing	 in	 Europe,	 and	 the	 differing	 serological	 responses	 of	 vaccinated	 to	
unvaccinated	pigs	should	be	considered	when	using	this	test	to	monitor	a	herd’s	NTS	status,	
as	positive	serological	results	in	vaccinated	animals	may	confuse	the	true	prevalence	of	NTS	
carriage	within	a	herd.		
In	developing	countries,	reduction	 in	the	frequency	of	co-morbidities	affecting	the	human	
population	 such	 as	 HIV,	 malaria	 or	 other	 immune-suppressive	 diseases	 will	 also	 be	
necessary	 in	 order	 for	 the	 incidence	 of	 clinical	 NTS	disease	 in	 humans	 to	 reduce.	 	 Policy	
management	 to	 address	 priorities	 in	 increasing	 food	 safety	 and	 hygiene	 in	 animal	
production	and	meat	processing	 in	LMICs	should	be	addressed.	Currently,	 it	can	be	found	
that	these	policies	are	only	loosely	implemented	in	some	slaughterhouses	in	LMICs,	as	the	
infrastructure	 for	 regulation	 that	 can	 be	 put	 in	 place	 in	 higher-middle	 income	 countries	
(HMICs)	is	not	possible	in	all	LMIC	settings.		
In	 industrialised	countries,	 regulation	of	 food-safety	 from	 ‘farm-to-fork’	 is	 fundamental	 to	
the	control	of	NTS	as	transmission	is	most	commonly	zoonotic	or	environmental.		Steps	to	
reduce	 the	 frequency	of	 the	 transmission	within	 these	countries	are	 common,	and	 in	 the	
EU,	 enforced	 by	 EU-wide	 directives.	 These	 steps	 include	 rodent	 control,	 effective	
biosecurity	 implementation,	 involving	 both	 access	 to	 the	 farm	 and	 whilst	 on	 farm,	
cleanliness	 of	 vehicles	 and	 personnel,	 appropriate	 waste	 management	 strategies,	 feed	
based	interventions,	which	involve	food	provided	to	be	of	low-pH,	so	discouraging	growth	
of	NTS	within	the	gastrointestinal	tract,	vaccination	against	NTS,	a	good	hygiene	policy	on	
farm	and	limited	movement	and	mixing	of	the	herd	with	unknown	animals	(Andres,	2015).		
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Aims	
. 	
The	 primary	 aim	 of	 this	 thesis	 was	 to	 determine	 and	 compare	 prevalence,	 diversity	 and	
strains	of	NTS	 in	pig	 samples	collected	at	post	mortem	 from	3	 slaughter	house	sites;	 two	
rural	(Busia,	Kenya	and	the	Chikwawa	Valley,	Malawi)	and	one	urban	(Nairobi,	Kenya)	areas.	
The	secondary	aim	was	to	determine	and	compare	antimicrobial	resistance	profiles	of	NTS	
present.	
	
Chapter	 2	 describes	 the	 design	 of	 the	 study	 and	 the	 sampling	 protocol	 and	 the	
microbiological	and	molecular	methods	employed	to	determine	the	presence	of	NTS	prior	
to	whole	genome	sequencing.		
	
Chapter	3	presents	results	of	prevalence,	diversity	and	strains	of	NTS	and	the	antimicrobial	
resistance	phenotypes	detected.		
	
The	 concluding	 discussion	 discusses	 the	 findings	 of	 this	 thesis	 in	 the	 context	 of	 current	
published	research.	
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Chapter	2:	Materials	and	Methods	
2.1	Study	overview	
Faecal	and	mesenteric	lymph	node	samples	were	collected	from	pigs	at	slaughter	at	three	
study	 sites	 in	 sub-Saharan	 Africa;	 Busia,	 in	 rural	 Kenya;	 Nairobi,	 in	 urban	 Kenya	 and	 the	
rural	Chikwawa	District;	Malawi.	 	This	cross-sectional	study	was	carried	out	over	an	eight-
week	period	 in	Kenya	 (October-December	2016)	and	a	 two	week	period	 in	Malawi	 (April-
May	2017).	NTS	were	 isolated	 from	 the	 samples	and	 the	 isolates’	 susceptibility	 to	 twelve	
antimicrobial	agents	was	determined.			All	NTS	isolates	were	submitted	for	whole	genome	
sequencing	and	presence	of	antimicrobial	resistance	determinants	investigated.		
Ethical	Consent	
Ethical	 consent	 for	 this	 study	 was	 obtained	 from	 the	 University	 of	 Liverpool	 Veterinary	
Research	 Ethics	 Committee	 (Reference	 number	 VREC465),	 the	 International	 Livestock	
Research	 Institute	 Ethics	 Committee,	 Nairobi,	 Kenya	 (IACUC	 reference	 number	 2016.19)	
and	 the	 College	 of	 Medicine	 Research	 Ethics	 Committee,	 Malawi	 (Reference	 number	
P.02/17/2124).	
2.2	Study	Population	
Pigs	 selected	 were	 those	 presenting	 for	 slaughter	 on	 the	 day	 of	 sample	 collection	 at	
designated	slaughterhouses	 in	the	three	study	sites.	 	 	Designated	slaughterhouses	 in	each	
location	were	chosen	as	those	which	were	geographically	convenient	for	the	study	team	to	
reach	daily.		In	Busia	and	Malawi,	all	sampling	locations	included	in	the	study	were	within	a	
ninety-minute	drive	from	the	laboratory	where	processing	was	to	take	place,	which	enabled	
samples	 to	 be	 collected	 from	 all	 slaughter	 slabs	 daily.	 	 All	 pigs	 presenting	 to	 the	
slaughterhouse	on	the	day	of	sampling	were	eligible	to	be	included	in	the	study.	Informed	
consent	was	obtained	from	all	owners,	Traders	and	the	slaughterhouse	owners.		Pigs	were	
sampling	according	to	the	capacity	of	the	fieldworkers.		 In	 the	 quieter	 slaughterhouses,	 all	
pigs	 were	 samples,	 but	 in	 the	 Ndumbuini	 slaughterhouse,	 Nairobi,	 where	 throughput	 is	
high,	as	many	pigs	as	possible	were	sampled	daily,	but	some	pigs	were	left	unsampled	if	at	
the	 time	 of	 carcass	 dressing	 the	 fieldworker	 was	 busy	 logging	 a	 previous	 sample.	 This	
occurred	randomly	and	there	was	no	selection	carried	out	by	the	fieldworkers	as	to	which	
pig	was	missed	or	sampled.		
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In	Nairobi,	Ndumbuini	slaughterhouse	was	sampled,	which	is	located	in	the	Kikuyu	District	
of	Kiambu	County	on	the	peri-urban	fringe	of	Kenya’s	capital	city	(Map	V,	Appendix).		This	is	
a	dedicated	 swine	 slaughterhouse	 receiving	pigs	 from	 the	whole	 country	 and	 is	 the	main	
supplier	 of	most	 of	 the	 butcheries	 in	 central	 Nairobi.	 	 No	 processing	 of	 pork,	 other	 than	
cutting,	is	carried	out	on	site.	The	slaughterhouse	has	a	capacity	of	40-50	pigs	slaughtered	
per	day.		The	majority	of	these	pigs	originate	from	Kiambu	and	surrounding	areas;	although	
some	originate	from	further	afield	in	Kenya	(see	Table	I,	Appendix).	Often	the	pigs	delivered	
to	this	slaughterhouse	have	been	reared	in	a	more	commercial,	intensive	environment	than	
pigs	 in	 Busia	 or	 Chikwawa.	 Slaughtering	 takes	 place	 via	 the	 ‘sticking	 method’	 following	
electrical	 stunning	 across	 the	 pigs’	 temples.	 A	 commercial,	 intensive	 system,	 with	
approximately	20	assistants	caters	for	the	processing	and	dressing	of	40-50	pigs	daily.		
In	 Busia	 samples	 were	 collected	 from	 seven	 different	 slaughter	 slabs,	 located	 within	 an	
hours’	 drive	 of	 Busia	 town.	 	 These	 slaughter	 slabs	 were	 Bumala,	 Matayos,	 Mundika,	
Mungatsi,	 Nambale,	 Tangakona	 and	 Funyula	 (see	Map	 I,	 Appendix).	 	 Each	 slaughter	 slab	
does	not	 run	operations	on	a	daily	basis,	generally	 functioning	on	specific	market	days	of	
the	 local	 town,	 therefore	 visits	 to	 the	 individual	 slaughter	 slabs	 were	 made	 on	 specific,	
functioning	days.	 	 The	 slaughter	 slabs	 cater	 for	1-15	pigs	each	per	working	day,	normally	
delivered	to	the	slaughterhouse	via	 individual	Traders	on	motorcycles	who	have	collected	
the	animal	from	the	original	village	in	which	it	was	reared.	Pigs	in	the	Busia	area	are	reared	
via	low-intensity	methods	as	free-roaming	animals,	scavenging	around	the	homesteads	and	
villages	 to	gain	access	 to	 food	 (Thomas,	2013).	Slaughtering	 takes	place	using	 the	sticking	
method.	No	stunning	was	employed	in	the	Busia	region.		
In	 the	Chikwawa	district,	Malawi,	 samples	were	 collected	 from	pork	butcheries,	 to	which	
slaughtermen	brought	 the	meat	 samples.	 For	 cultural	 reasons,	 slaughtering	of	pigs	 in	 the	
rural	Chikwawa	district	occurs	in	the	compounds	of	the	owners.	One	compound	was	visited	
in	 order	 to	 obtain	 faecal	 and	mesenteric	 lymph	 node	 samples	 from	 three	 pigs,	 however	
logistics	 dictated	 that	 following	 instruction	 from	 the	 Field	 Team,	 the	majority	 of	 samples	
were	 collected	 by	 slaughter	men	 at	 the	 point	 of	 slaughter	 prior	 to	 carcass	 dressing,	 and	
brought	 to	 the	 butchery	 within	 two	 hours	 of	 slaughter,	 where	 they	 were	 collected	 and	
transported	 at	 4°C	 to	 the	 laboratory	 for	 processing.	 	 Sample	 collection	 took	 place	 from	
butcheries	 located	 in	 three	 towns	 in	 the	 Chikwawa	District;	 Chikwawa	 town,	 Nchalo	 and	
Ngabu	 (see	 Map	 III,	 Appendix).	 A	 variety	 of	 slaughtering	 methods	 was	 employed	 to	
slaughter	the	pigs	in	the	Chikwawa	District,	these	include	sticking	and	hanging.	No	stunning	
techniques	prior	to	slaughter	were	employed.		
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2.3	Sample	size	calculation	
Sample	 size	 was	 calculated	 using	 an	 estimated	 prevalence	 of	 carriage	 of	 non-typhoidal	
Salmonella	 in	 the	 pig	 population	 of	 10%	 (Kariuki,	 2002)	 using	 a	 3%	 precision	 and	 95%	
confidence	interval.	Adjustment	for	clustering	at	the	three	sample	sites	was	made	using	the	
formula	n1	 =	n(1+p(m-1)),	 see	below.	 	 The	 intra-class	 coefficient	was	estimated	 to	be	0.1	
and	samples	were	taken	from	three	sites.		 
Formula	n1	=	n(1+p(m-1))	
New	sample	size			=	384(1+0.1	(3-1)	=	461	samples.	
Therefore	461/3=154	pigs	to	be	sampled	from	each	of	the	three	sites.	
n=	 sample	 size	 using	 estimated	 prevalence	 of	 10%,	 95%	 CI	 and	 3%	 precision	 and	 a	 large	
population	size		
p=	ICC	
m=	number	of	sites	where	samples	will	be	taken	
n1	=	sample	size	corrected	for	clustering	
2.4	Sample	collection	
Faecal	and	mesenteric	lymph	node	samples	were	taken	from	pigs	post	mortem.		From	each	
pig	sampled,	between	1-25g	faeces	was	taken	manually	from	the	rectum.		Once	the	entire	
gastrointestinal	 tract	 had	 been	 removed	 during	 meat	 processing	 between	 1-4g	 of	
mesenteric	lymph	node	tissue	was	excised	using	a	sterile	scalpel	blade.		This	tissue	sampled	
was	 composed	 of	 at	 least	 five	 individual	 mesenteric	 lymph	 nodes	 located	 in	 various	
different	 areas	 of	 the	 mesentery	 of	 the	 small	 and	 large	 intestine.	 Approximately	 three	
lymph	 node	 samples	were	 taken	 from	 the	mesentery	 of	 the	 ileum	 and	 jejunum	and	 two	
samples	were	taken	from	the	colonic	mesentery,	to	total	1-4g.	
The	samples	were	placed	into	individual	sterile	containers	which	were	collected	in	a	chilled	
box	 (4°C).	 	 Samples	 reached	 the	 laboratory	 and	 were	 processed	 within	 four	 hours	 of	
collection.				
Additional	 data	 were	 collected	 on	 paper	 and	 electronically	 using	 a	 ‘Field	 Information	
Support	Tool’	developed	 from	a	Case	Report	Form	by	 the	Kestrel	Technology	Group	on	a	
	 35	
Nexus	5	Android	device.		This	questionnaire	included	name	of	the	village	where	the	pig	was	
reared,	previous	antibiotic	treatment	if	known,	age,	sex	and	breed	of	pig	as	well	as	method	
of	transport	of	the	pig	to	slaughterhouse,	where	possible,	from	either	the	owner	of	the	pig	
or	the	tradesman	who	had	brought	the	animal	to	the	slaughterhouse.		The	GPS	location	of	
each	of	the	slaughterhouses	was	recorded	using	a	Nexus	5	device.	
2.5	Salmonella	Isolation	
Samples	were	processed	once	they	reached	the	 laboratory	within	 four	hours	of	 the	 initial	
sampling.	 	 NTS	 isolation	 and	 culture	 (based	 on	 Standard	 Procedures,	 International	
Organisation	 for	 Standardisation	 (ISO	 6579:2002,	 Ikwap,	 2014),	 serotyping	 and	
antimicrobial	 susceptibility	 testing	 took	 place	 at	 the	 Directorate	 of	 Veterinary	 Services-
International	 Livestock	 Research	 Institute,	 (DVS-ILRI)	 Zoonoses	 Laboratory,	 Busia,	 ILRI	
Laboratories,	Nairobi	and	the	University	of	Liverpool-Wellcome	Trust	laboratories,	based	at	
the	Malawi-Liverpool	Wellcome	Trust	Centre,	Blantyre,	Malawi.	 	 ISO	 is	a	global	 federation	
of	national	standards	bodies.	Publication	of	an	International	Standard	requires	approval	by	
at	least	75%	of	the	member	bodies.		
The	 exterior	 of	 the	 surface	 of	 each	 of	 the	 mesenteric	 lymph	 node	 samples	 was	 placed	
briefly	into	a	flame	to	remove	any	residual	exterior	contamination.		1g	of	mesenteric	lymph	
node	 (composed	 of	 parts	 of	 five	mesenteric	 lymph	 nodes	 from	multiple	 locations	 in	 the	
gastrointestinal	tract)	and	1g	of	faeces	from	each	pig	were	placed	into	separate	stomacher	
bags	 containing	 9ml	 2%	 buffered	 peptone	 water.	 	 Samples	 were	 homogenized	manually	
and	placed	into	sterile	bijou	bottles.	Each	sample	was	incubated	for	18	hours	at	37°C.		All	of	
the	media	used	to	undertake	the	protocol	was	purchased	from	Oxoid	Ltd.,	Basingstoke,	UK,	
apart	from	the	Harlequin	ABC	Salmonella	agar	which	is	manufactured	by	Lab	M,	Bury,	UK.		
Following	pre-enrichment,	0.1ml	of	each	sample	was	placed	into	a	sterile	bijou	containing	
9.9ml	Rappaport-Vassiliadis	broth.		These	were	incubated	for	24	hours	at	42°C.	
Each	 enriched	 sample	 was	 inoculated	 onto	 both	 Brilliant	 Green	 agar	 and	 Harlequin	 ABC	
Salmonella	plates.	All	plates	were	incubated	for	24	hours	at	37°C.		
The	plated	growths	were	assessed	and	 those	colonies	with	 the	appearance	of	Salmonella	
growth	were	 isolated.	 	On	 the	Brilliant	Green	 agar	 plates	 this	 included	pink	 colonies	 and	
green	 colonies	 from	 the	 Harlequin	 ABC	 Salmonella	 agar	 plates.	 	 These	 positive	 colonies	
were	inoculated	onto	nutrient	agar	plates	and	incubated	for	a	further	24	hours	at	37°C	prior	
to	antisera	agglutination	and	antimicrobial	susceptibility	testing.		
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2.6	Salmonella	confirmation	by	serotyping	
A	 small	 part	 of	 the	 suspect	NTS	 colony	was	 taken	 from	 the	 overnight	 culture	 and	mixed	
thoroughly	with	a	drop	of	sterile	saline	on	a	clean	glass	slide	using	a	sterile	microloop.		One	
drop	of	 Salmonella	 antisera	 (Poly	O	 antigen	 and	H	Phase	 1	 and	2	 or	H	Phase	 2	 antigens,	
Prolab,	 Ontario,	 Canada)	 was	 added	 to	 one	 aliquot	 of	 bacterial	 suspension	 and	 further	
mixing	 with	 a	 sterile	 loop	 occurred.	 The	 slide	 was	 gently	 tilted	 back	 and	 forth	 for	 one	
minute	 and	 agglutination	 was	 assessed	 for	 under	 normal	 lighting	 conditions.	 	 Where	
agglutination	 was	 seen	 to	 occur	 the	 isolate,	 taken	 from	 the	 nutrient	 agar	 culture,	 was	
stored	 into	a	microbank	 tube,	 frozen	at	 -80°C	and	 transported	 to	 the	UK,	where	PCR	was	
carried	out	followed	by	whole	genome	sequencing	for	those	samples	that	yielded	a	positive	
PCR	 result.	 	 Antisera	 testing	 was	 carried	 out	 for	 all	 isolates	 using	 the	 O	 antigen,	 and	 all	
isolates	from	Busia	using	both	the	O	and	H	antigens.		
2.7	Antimicrobial	Susceptibility	Testing	
The	disc	diffusion	method	was	carried	out	in	accordance	with	the	European	Committee	on	
Antimicrobial	Susceptibility	Testing	guidelines	(EUCAST,	2016).	All	assumed	isolates	of	NTS,	
positive	on	agglutination	 testing,	underwent	antimicrobial	 susceptibility	 testing.	 	Using	an	
inoculating	loop,	3-5	isolated	colonies	were	taken	from	the	plate.	The	colonies	were	added	
to	1ml	sterile	saline	to	create	a	solution	of	0.5	McFarland	standard	(McFarland,	1907).		The	
solution	was	mixed	well	and	a	sterile	cotton-tipped	swab	was	placed	 into	the	suspension.	
The	entire	 surface	of	 two	Mueller	Hinton	plates	was	 inoculated	by	 streaking	 the	 solution	
over	the	entire	area.	Antimicrobial	discs	were	applied	within	15	minutes	of	inoculating	the	
Mueller	 Hinton	 plate.	 Twelve	 antimicrobial	 discs	 were	 placed	 firmly	 onto	 the	 agar.	 The	
antimicrobial	 discs	 and	 their	 potencies	 were:	 ampicillin	 (10ug),	 amoxycillin-clavulanate	
(20ug/10ug),	 streptomycin	 (10ug),	 ceftazidime	 (30ug),	 kanamycin	 (30ug),	 ciprofloxacin	
(5ug),	 cefoxitin	 (30ug),	 trimethoprim-sulphamethoxazole	 (25ug),	 cefotaxime	 (30ug),	
gentamicin	(10ug),	chloramphenicol	(30ug)	and	tetracycline	(30ug)	(Behl,	2017,	Choudhard,	
2013,	Kebede,	2016,	Maka,	2014	Poudel,	2014).		Kanamycin	was	not	available	to	use	as	part	
of	 the	 disc	 diffusion	 protocol	 in	 Busia,	 therefore	 gentamicin	was	 used	 in	 its	 stead	 during	
antimicrobial	susceptibility	testing	of	NTS	from	this	location.		Plates	were	incubated	at	37°C	
for	16-18	hours.	 	After	 this	 time,	 the	diameter	of	 the	 zones	of	 inhibition	was	 recorded	 in	
millimetres	 and	 recorded	 as	 resistant,	 intermediate	 or	 sensitive	 in	 accordance	 with	 the	
EUCAST	guidelines	(EUCAST,	2016).			
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2.8	Polymerase	Chain	Reaction	
All	 isolates	 from	 Busia	 and	 Nairobi	 slaughter	 slabs	 which	 gave	 positive	 results	 on	 the	
Salmonella	spp.	antisera	test	were	submitted	for	PCR	to	confirm	the	presence	of	NTS.		This	
was	 carried	 out	 in	 the	 University	 of	 Liverpool,	 Leahurst	 Campus	 Laboratories,	 United	
Kingdom.		PCR	testing	was	not	carried	out	on	isolates	from	Malawi	due	to	delays	in	shipping	
of	samples	to	the	UK.		
Preparation	of	DNA	
A	 loop	of	 culture	was	 taken	 from	 the	microbank	 tube,	 inoculated	onto	nutrient	 agar	 and	
cultured	 for	 24	 hours	 at	 37°C.	 Using	 a	 sterile	 microloop,	 3-5	 colonies	 of	 this	 overnight	
culture	were	placed	into	a	1.5ml	microcentrifuge	tube	containing	300ul	of	ultra-pure	water.			
The	samples	were	boiled	at	100°C	using	a	heat	block	for	10	minutes	in	order	to	lyse	the	cells	
and	release	the	DNA.			
After	 the	 solutions	 had	 cooled,	 the	 NanoDrop	 machine	 was	 used	 to	 demonstrate	 that	
sufficient	DNA	was	present	prior	to	the	PCR	testing.		
Primers	
The	primers	to	detect	presence	of	the	tetrathionate	reductase	gene	which	is	constitutively	
present	in	all	Salmonella	spp.	(Malorny,	2004).		The	primers	used	were	ttr-4	and	ttr-6,	made	
up	and	supplied	by	Eurofins	(www.Eurofinsgenomics.eu).			
Designation	 Sequence	 Melting	Temperature	(°C)	
ttr-6	(forwards)	 CTCACCAGGAGATTACAACATGG	 57	
ttr-4	(backwards)	 AGCTCAGACCAAAAGTGACCATC	 58	
Table	1.	DNA	sequence	of	primers	used	
PCR	Assay	
The	PCR	reaction	mixture	contained	My	TaqTM		Red	Mix	(25ul,	Bioline,	London,	UK),	forward	
(ttr-4)	and	reverse	 (ttr-6)	 tetrathionate	primers	 (20uM	each),	pure	water	 (up	to	50ul)	and	
200ng	DNA	template	in	a	total	volume	of	50ul.		A	positive	control	(S.	Typhimurium	DT104),	
and	negative	control	(pure	water,	no	DNA	template)	was	also	used.		PCRs	were	performed	
using	Starlab	(Milton	Keynes,	UK)	wells	closed	with	Starlab	caps.	 	Samples	were	run	using	
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the	 Applied	 Biosystem	 0.2720	 Thermal	 Cycler	machine.	 	 The	 conditions	 for	 the	 reactions	
were	95°C	for	3	minutes	for	initial	denaturation,	30s	at	95°C	for	denaturation.	30s	at	55°C	
for	annealing	 to	occur,	 followed	by	a	30	 second	extension	phase	at	72°C	 repeated	 for	35	
cycles.	
2.9	Whole	genome	sequencing	
The	pathway	by	which	a	decision	was	made	as	to	whether	samples	were	submitted	for	WGS	
is	 laid	 out	 in	 Figure	 4	 and	 5;	 Results.	 	 Samples	were	 submitted	 for	WGS	 to	 the	 Earlham	
Laboratory,	 Norwich	 as	 part	 of	 the	 10,000	 Salmonella	 Genome	 Project	 (http://10k-
salmonella-genomes.com,	 last	accessed	26th	November	2017).	DNA	extraction	preparation	
for	sequencing	was	carried	out	by	the	Earlham	Laboratory.		Illumina	short-read	sequencing	
was	carried	out	on	these	samples.		In	total	259	isolates	were	submitted	for	whole	genome	
sequencing.		
3.0	Analysis	of	results	
The	database	Enterobase	was	used	to	analyse	results	of	 the	72	S.	enterica	genomes	 from	
which	sequencing	had	been	completed	at	the	time	of	writing.		The	accession	numbers	and	
further	 information	 of	 these	 isolates	 can	 be	 found	 in	 the	 results	 and	 on	 Enterobase	
(https://enterobase.warwick.ac.uk,	 last	 accessed	 5th	 January	 2018).	 	 Enterobase	 is	 a	 free,	
online	 tool	 for	 visualising	 genetic	 variation	 within	 enteric	 bacteria,	 providing	 assembled	
genomes	and	associated	metadata	on	 strain	properties	 for	public	 access.	 	Genomes	have	
been	assembled	de	novo	from	Illumina	reads	from	the	Earlham	Laboratory	and	genotyping	
data	 has	 been	 deduced	 exclusively	 from	 the	 assemblies	 using	 this	 programme.	 	 The	
sequence	 types,	 and	 subsequent	 serovars,	 have	 been	 deduced	 using	 the	 Enterobase	
program.	 	 	 The	accession	numbers	of	 the	72	positive	 samples	 are	provided	 in	 the	 results	
section.		
3.1	Statistical	Analysis	
Descriptive	statistics	with	a	95%	confidence	interval	were	used	to	describe	the	prevalence	
and	 diversity	 of	 NTS	 detected.	 	 The	 frequency	 and	 diversity	 of	 the	 antimicrobial	
susceptibility	 phenotypes	 of	 the	 NTS	 detected	 were	 also	 analysed	 using	 descriptive	
statistics	with	a	95%	confidence	interval.		Prevalences	discussed	here	were	compared	only	
visually	and	graphically,	no	further	statistical	tests	have	been	used	to	analyse	the	data	from	
this	study.		
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Case	definition:	
Final	case	definition	is	any	isolate	confirmed	to	be	NTS	by	whole	genome	sequencing.	Those	
isolates	 which	 appear	 to	 be	 NTS	 following	 selective	 culture	 and	 antigen	 serotyping	 but	
results	of	whole	genome	sequencing	have	not	yet	been	returned	were	not	be	counted	as	a	
case	of	NTS.		
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Chapter	3:	Results	
Introduction	and	Main	Findings	
I) Prevalence,	diversity	and	strains	of	NTS	
A	variety	of	zoonotic	serovars	of	NTS	were	detected	in	faecal	and	mesenteric	lymph	nodes	
of	 pigs	 at	 each	 site,	 including	 S.	 Typhimurium	 and	 S.	 Enteritidis.	 	 One	 isolate	 of	 S.	
Typhimurium	 ST313	was	 identified	 in	 the	mesenteric	 lymph	 node	 of	 a	 pig	 slaughtered	 in	
Nairobi,	Kenya	and	 four	unique	 isolates	of	S.	Typhimurium	ST19	were	detected	 in	pigs	at	
slaughter	 in	 Nairobi.	 Unfortunately,	 it	 is	 currently	 impossible	 to	 offer	 an	 accurate	
prevalence	 of	NTS	 in	 samples	 submitted	 from	 the	 three	 study	 sites	 as	 only	 partial	whole	
genome	sequencing	results	from	each	of	the	three	sites	have	yet	to	be	returned,	therefore	
definite	confirmation,	according	to	the	case	definition,	that	the	isolates	were	NTS	cannot	be	
offered,	rendering	any	current	true	prevalence	inaccurate.		
II) Antimicrobial	resistance	profile	of	NTS	detected	
Two	multi-drug	resistant	(MDR)	isolates	(resistant	to	three	or	more	classes	of	antibiotics)	of	
NTS	 were	 detected	 in	 pigs	 slaughtered	 in	 Busia.	 	 10%	 of	 current	 confirmed	 NTS	 isolates	
from	Busia	(4/39,	CI	4-24%)	and	14%	of	current	confirmed	NTS	isolates	from	Nairobi	(3/22,	
CI	 5-3%)	 were	 resistant	 to	 1-2	 antimicrobials.	 A	 range	 of	 different	 antimicrobial	
susceptibility	 phenotypes	 were	 present,	 including	 resistance	 to	 the	 third-generation	
cephalosporin	ceftazidime	(1/61,	1.6%,	CI	0.3-8.7%	of	total	confirmed	unique	NTS	isolates)	
and	the	fluoroquinolone,	ciprofloxacin	(2/61,	3.3%,	CI	0.9-11.2%	of	total	confirmed	unique	
NTS	isolates).	
Study	population	
Mesenteric	 lymph	 node	 and	 faecal	 samples	 were	 taken	 from	 pigs	 following	 slaughter	 in	
three	 geographical	 areas	 (Figure	 1).	 In	 total,	 306	 pigs	 were	 sampled	 in	 Ndumbuini	
slaughterhouse,	Nairobi,	267	in	Busia	county	and	65	pigs	in	Malawi.	In	total	638	pigs	were	
sampled	during	the	study	period.	
	
	 41	
	
Figure	1.	Location	of	the	three	study	sites	Nairobi	and	Busia,	Kenya	and	Chikwawa	Valley,	
Malawi		
Sampling	sites	and	locations	pigs	were	reared	
• Busia,	Kenya	
Up	to	20	samples	were	collected	daily	over	a	six-week	period	October-November	2016	from	
seven	slaughter	slab	locations	across	Busia	county.	Fewer	than	20	pigs	are	slaughtered	daily	
at	 each	 slab	where	 samples	were	 collected,	 and	 sampling	 from	multiple	 sites	 daily	 fitted	
with	 the	 project	 schedule.	 	 The	 number	 of	 pigs	 sampled	 at	 each	 slaughter	 slab	 in	 Busia	
county	is	shown	in	Table	1.		
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Name	of	Slaughterslab	in	
Busia	County	
Number	of	pigs	sampled	at	
this	slaughterslab	during	this	
study	
Percentage	of	total	pigs	
sampled	in	Busia	(%)	
Mundika	 124	 46	
Tanga	kona	 16	 6	
Nambale	 28	 10	
Funyula	 11	 4	
Matayos	 35	 13	
Bumala	 39	 15	
Mugatsi	 7	 3	
Unknown	slaughter	slab	within	
Busia	county	
7	 3	
Table	 2.	 Number	 of	 pig	 samples	 collected	 from	 the	 slaughter	 slabs	 visited	 across	 Busia	
county	during	the	study.	
• Nairobi,	Kenya	
Nairobi	 samples	 were	 collected	 daily	 from	 up	 to	 60	 pigs	 from	 the	 Ndumbuini	 abbatoir	
(Figure	2a)	 over	 a	 two-week	period	November-December	2016.	 In	 total	 of	 306	pigs	were	
sampled.	 	 Pigs	 slaughtered	 in	 Ndumbuini	 slaughterhouse,	 Nairobi	were	 reared	 in	 various	
geographical	locations.	The	majority	of	pigs	originated	from	the	suburbs	of	Nairobi	and	the	
surrounds,	but	 some	had	 travelled	 from	as	 far	 afield	as	Homa	Bay,	Kisumu,	 a	distance	of	
approximately	350km.	
• Chikwawa	District,	Malawi	
In	Malawi	up	to	10	samples	were	collected	daily	over	a	two	week	period	during	April	2017,	
from	butcheries	and	slaughter	sites	located	in	three	towns	in	the	Chikwawa	District	(Figure	
2c);	Nchalo,	Ngabu	and	Chikwawa	Town.		In	rural	Malawi	pigs	are	either	slaughtered	in	the	
back	yard	of	the	owner	or	the	slaughter	man,	prior	to	carcass	processing	in	this	location.		It	
was	 found	 that	meat	was	 then	 transported	 uncontained,	 on	 foot	 or	 via	 a	 non-motorised	
bicycle,	to	the	butchery.	In	Chikwawa	Town	samples	were	collected	from	the	slaughter	site	
of	the	pigs	which	was	the	back	yard	of	the	slaughter	man.		In	Nchalo	and	Ngabu	it	was	not	
possible	 to	 access	 the	 slaughter	 site	 and	 therefore	 four	 butcheries	 in	 Nchalo	 and	 two	
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butcheries	 in	Ngabu	were	 visited	 and	 sample	 collection	was	 carried	 out	 directly	 at	 these	
butcheries.	
Figure	2.	Examples	of	slaughterhouses	where	samples	were	collected	at	each	of	the	
different	study	sites	
	
a)	Ndumbuini	slaughterhouse,	Nairobi	
	
b)	Bumala	slaughterslab,	Busia	County	
	
c)	Chikwawa	Town	slaughterslab	
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Age	of	pigs	
The	 age	of	 the	pigs	 sampled	was	 estimated	 to	 range	 from	3	months	 to	 2.5	 years,	with	 a	
mean	of	 14	months	 in	Busia	 and	19	months	 in	Malawi.	 This	was	unable	 to	be	defined	 in	
Nairobi	as	 it	was	not	possible	to	collect	data	regarding	the	age	of	the	pigs,	given	the	fast-
paced	slaughterhouse	environment.	 	 In	Nairobi	samples	were	taken	from	113	female	pigs,	
114	male	pigs	and	79	pigs	of	unknown	sex.	In	Busia	samples	were	taken	from	146	females	
and	 101	male	 pigs	 (10	 of	which	were	 castrated)	 and	 20	 pigs	 of	 unknown	 sex.	 In	Malawi	
samples	were	taken	from	42	female	pigs,	22	male	pigs	(5	of	these	were	castrated)	and	one	
pig	of	unknown	sex.		
Breed	of	pigs	
The	most	common	breed	sampled	was	a	mixed	breed	white	haired	pig,	 likely	a	mix	of	the	
Landrace	and	large	white	breeds	(Figure	3b).	One	hundred	percent	of	the	pigs	sampled	 in	
Nairobi	were	of	this	breed	and	30%	of	pigs	in	Busia.	In	Busia	other	breeds	sampled	included	
the	Duroc	 (4%)	and	a	 local	black	breed	 in	Kenya	 (19%)	and	a	 local	black	and	white	breed	
(20%)	 (Figure	 3a).	 The	 breed	 of	 the	 remaining	 percentage	 of	 pigs	 was	 unknown.	 	 In	
Chikwawa,	Malawi	98%	of	the	study’s	pig	population	were	the	local	black	and	white	breed	
(Figure	3c),	and	2%	were	unknown	or	unrecorded.		
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Figure	3.	Examples	of	‘typical’	local	pig	breeds	sampled	at	each	of	the	three	study	sites;	
	
a)	Busia	
	
b)	Nairobi	
	
c)	Malawi	
Transport	of	pigs	to	slaughter	slabs	
In	Nairobi	pigs	were	mostly	transported	to	the	slaughterhouse	singly	or	in	small	groups	by	
pick-up	 truck.	 In	Busia	almost	all	pigs	were	 transported	 to	 the	slaughterhouse	singly	on	a	
motorbike.		
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Previous	antibiotic	treatment	
It	was	not	possible	 to	reliably	determine	whether	previous	antibiotic	 treatment	had	been	
administered	 to	 the	 pigs,	 as	 the	 animals	 were	 mostly	 brought	 to	 the	 slaughter	 slab	 or	
butchery	 by	 a	 Trader	 rather	 than	 an	 owner,	 and	 this	 Trader	 was	 not	 aware	 of	 the	
information.	 In	 the	six	cases	where	 it	was	known	that	 the	pigs	had	been	given	antibiotics	
within	the	last	3	months,	it	was	not	known	which	antibiotic	had	been	administered	and	at	
which	dose	and	whether	the	owner	of	the	pig	had	taken	the	drug’s	withdrawal	period	into	
account	 when	 choosing	 the	 day	 for	 slaughter.	 	 These	 six	 previously	 treated	 animals	 all	
originated	from	Busia.	It	was	not	possible	to	find	out	information	regarding	prior	antibiotic	
treatment	in	either	Nairobi	or	Malawi.	
Total	number	of	faecal	and	mesenteric	lymph	node	samples	collected	from	each	location	
Selective	culture	NTS	was	undertaken	of	both	mesenteric	 lymph	node	and	 faecal	samples	
collected	from	each	pig	in	Busia,	Nairobi	and	Malawi	on	both	brilliant	green	and	Harlequin	
ABC	Salmonella	agar.	In	occasional	cases	either	a	faecal	or	mesenteric	lymph	node	sample	
from	 a	 pig	 was	 not	 collected	 and	 therefore	 only	 one	 sample	 was	 collected	 from	 each	
animal.	 The	 total	 numbers	 of	 samples	 collected	 in	 each	 sample	 location	 are	 detailed	 in	
Table	3	below.		
Sample	site	and	total	
number	of	pigs	
sampled	
Number	of	pigs	at	
each	site	from	which	
faecal	and	
mesenteric	lymph	
node	samples	
collected	
Number	of	pigs	at	
each	site	from	which	
faecal	sample	only	
was	collected	
Number	of	pigs	at	
each	site	from	which	
mesenteric	lymph	
node	sample	only	
was	collected.	
Busia	county	
(N=267)	
265	 2	 0	
Nairobi	(N=306)	 306	 0	 0	
Chikwawa	District	
(N=65)	
52	 1	 12	
Table	3.	Number	of	mesenteric	lymph	node	and	faecal	samples	collected	and	submitted	for	
selective	NTS	culture	at	each	location.		
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Non-typhoidal	Salmonella	detected	
Prevalence	of	NTS	in	samples	
As	stated	above,	selective	culture	for	NTS	was	undertaken	of	both	mesenteric	lymph	node	
and	 faecal	 samples	collected	 from	each	pig	 in	Busia,	Nairobi	and	Malawi	on	both	brilliant	
green	and	Harlequin	ABC	Salmonella	agar.	 	NTS	was	detected	by	positive	selective	culture	
on	 either	 or	 both	 of	 Harlequin	 ABC	 Salmonella	 agar	 and	 brilliant	 green	 agar,	 O	 antigen	
serotyping	 and/or	 PCR.	 	 Positive	 isolates	 were	 submitted	 for	 whole	 genome	 sequencing	
(WGS)	 (see	 Figure	 4	 and	 5).	 	 N.B.	 PCR	 was	 not	 undertaken	 on	 isolates	 collected	 from	
Malawi,	therefore	all	isolates	which	gave	a	positive	‘O	antigen’	serotype	result	from	Malawi	
were	submitted	for	whole	genome	sequencing;	Figure	5)		
Therefore,	 110	 positive	NTS	 isolates	were	 submitted	 for	whole	 genome	 sequencing	 from	
pigs	 slaughtered	 in	Nairobi,	which	originate	 from	a	 total	of	80	pigs.	 57	NTS	 isolates	were	
submitted	 from	 38	 pigs	 in	 the	 Chikwawa	 Valley,	Malawi	 and	 92	 NTS	 isolates	 from	 Busia	
county	were	submitted	from	a	total	of	63	pigs.	In	total,	259	NTS	isolates	were	submitted	for	
whole	 genome	 sequencing	 at	 the	 Earlham	 Laboratory,	 Norwich,	 as	 part	 of	 the	 10,000	
Salmonella	genome	sequencing	project	(http://10k-salmonella-genomes.com)	
Estimated	 Prevalence	 of	 NTS	 using	 positive	 isolates	 of	 selective	 culture,	 O	 antigen	
serotyping	+/-	PCR	(see	Table	3)	
The	 estimated	 prevalence	 of	 NTS	 in	 pigs	 in	 Chikwawa	 (38/55,	 58%,	 CI	 46.5-70.4%)	 was	
found	 to	be	 significantly	 higher	 than	 in	pigs	 in	Nairobi	 or	Busia.	 There	was	 a	 significantly	
lower	prevalence	of	NTS	detected	in	faecal	samples	of	pigs	in	Busia	(34/267,	12.7%,	CI	8.7-
16.7%),	than	the	two	other	study	locations	and	the	estimated	prevalence	of	NTS	detected	
in	 mesenteric	 lymph	 node	 samples	 in	 Chikwawa	 (29/65,	 44.6%,	 CI	 33.1-57.5%)	 was	
significantly	higher	than	that	the	other	two	other	study	sites.	The	estimated	prevalence	of	
NTS	detected	 in	both	faecal	and	mesenteric	 lymph	node	samples	from	the	same	pigs	was	
significantly	 higher	 in	Chikwawa	 (7/38,	 18.4%,	CI	 6.1-30.7%)	 than	 in	Busia	 (6/63,	 9.5%,	CI	
2.3-16.8%).	The	 full	 results	of	 the	PCR	have	not	been	 included	 in	 this	 thesis	because	 they	
were	 not	 consistent	with	 the	 culture	 and	 sensitivity	 results,	 nor	 the	 results	 of	 the	whole	
genome	sequencing	which	have	currently	been	returned,	therefore	were	not	considered	to	
provide	 accurate	 or	 reliable	 results.	 	 This	 was	 thought	 to	 occur	 as	 the	 PCR	 experiments	
were	carried	out	under	time	pressure,	as	the	first	time	that	the	operator	had	performed	a	
PCR	procedure.		
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Results	of	whole	genome	sequencing	
To	date,	whole	 genome	 sequencing	data	has	been	 returned	 from	159	 isolates.	 	 These	 all	
originate	from	Kenya	(65	from	Busia,	94	from	Nairobi).	72	(45.3%	of	the	total	submitted	for	
whole	 genome	 sequencing)	 of	 these	 samples	 were	 found	 to	 be	 positive	 for	 NTS,	 the	
remainder	were	found	to	be	bacterial	isolates	other	than	NTS.		
Positive	NTS	isolates	
46	 of	 these	 positive	 NTS	 isolates	 originate	 from	 slaughterhouses	 in	 Busia	 and	 26	 from	
Nairobi.		A	table	to	show	the	positive	NTS	isolates	currently	confirmed	on	WGS	is	shown	in	
the	Appendix	(Table	I).		
Duplicate	NTS	isolates	
In	total	20	‘duplicate’	isolates	from	Nairobi	and	Busia	and	12	from	Malawi	were	submitted	
for	whole	genome	sequencing.	A	‘duplicate’	in	this	case	can	be	defined	as	two	isolates	from	
one	pig	which	both	originate	 from	the	same	 tissue	source	 (eg	either	both	 from	the	same	
mesenteric	 lymph	 node	 sample	 or	 the	 same	 faecal	 sample)	 and	 which	 have	 cultured	
positive	on	both	Harlequin	ABC	Salmonella	agar	and	Brilliant	agar,	as	well	as	both	providing	
a	 positive	 ‘O’	 antigen	 serotyping	 test	 and	 PCR	 result.	 	 A	 diagram	 to	 explain	 how	 this	
occurred	using	given	the	method	is	shown	in	Figure	4	below.	
Figure	4.	Sequence	of	methods	used	in	Kenya.		
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Figure	5.	Sequence	of	methods	used	in	Malawi	
	
Of	 the	 72	 positive	 NTS	 genomes	 results	 received	 currently,	 16	 of	 these	 were	 from	 pigs	
which	 had	 ‘duplicate’	 submissions	 to	WGS,	 either	 from	 faecal	 or	mesenteric	 lymph	 node	
samples.		These	16	‘duplicate’	samples	comprised	of	12	from	Busia	and	4	from	Nairobi	(see	
Table	 I,	 Appendix).	 	 These	 duplicates	 were	 considered	 identical	 if	 the	 serovar,	 sequence	
type	and	antimicrobial	resistance	phenotype	were	shared	exactly	between	the	two	isolates.		
In	 5	 ‘duplicate’	 samples	 from	 Busia,	 although	 the	 serovar	 allocated	 by	 whole	 genome	
sequencing	 was	 the	 same	 between	 the	 duplicates,	 either	 the	 sequence	 type	 or	
antimicrobial	 susceptibility	 profile	 were	 different.	 This	 suggests	 that	 ‘duplicate’	 isolates	
actually	were	unique	 and	 that	 the	 tissue	 source	 (either	 faecal	 or	mesenteric	 lymph	node	
from	one	pig)	may	be	carrying	two	distinct	NTS,	as	shown	in	Table	4	below.		
	
	
	
	
	
	 50	
Kenyan	
Number	
Tissue	sample	
originated	
from	
NTS	
positive?	
Serovar	 Sequence	
type		
Antimicrobial	
resistance	profile	
72	 MLN	HAC	 Yes	 Stanleyville	 1986	 Multi-drug	
resistant	
72	 MLN	BGA	 Yes	 Stanleyville	 912	 Susceptible	
Table	 4.	 Illustrates	 the	 detection	of	 5	 ‘non-identical	 duplicate’	NTS,	 one	of	 five	 examples	
from	Busia.		In	this	case	although	the	NTS	have	been	isolated	from	the	same	tissues	and	pig	
and	the	serovar	is	identical,	the	sequence	type	and	antimicrobial	resistance	profile	differ.		
For	 the	purpose	of	 this	 thesis,	 those	 five	salmonellae	with	 identical	 serovars	but	differing	
sequence	 types	 and/or	 antimicrobial	 susceptibility	 profiles	 were	 therefore	 counted	 as	
unique	isolates.	Eleven	duplicate	isolates	have	currently	been	sequenced	(7	from	Busia	and	
4	from	Nairobi).	This	is	illustrated	in	Table	5	below.	
Therefore	 61	 unique	 NTS	 isolates	 have	 completed	 whole	 genome	 sequencing;	 39	 from	
Busia	and	22	from	Nairobi	(see	Table	5	below).				
Location	 Total	number	of	WGS	
results	returned	(N=72)	
Character	of	isolate	 Number	
Busia	 46	 Duplicate	isolates	 7	
Unique	isolates	 39	
Nairobi	 26	 Duplicate	isolates	 4	
Unique	isolates	 22	
Table	 5.	Number	 of	 unique	 and	 duplicate	 isolates	 of	 NTS	 currently	 identified	 from	 each	
location.	
Two	 isolates	 were	 found	 to	 be	 novel	 serovars	 of	 NTS	 previously	 unidentified	 by	 whole	
genome	sequencing,	both	from	pigs	slaughtered	in	Nairobi	(see	Table	I,	Appendix).	
Unique	faecal	and	mesenteric	lymph	node	isolates	from	Nairobi	and	Busia	
Therefore,	in	total,	from	Nairobi	12	mesenteric	lymph	node	NTS	isolates	and	10	faecal	NTS	
isolates	 have	 been	 confirmed	 by	 whole	 genome	 sequencing.	 From	 Busia	 11	 faecal	 NTS	
isolates	and	28	mesenteric	lymph	node	NTS	isolates	have	been	confirmed.			
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Salmonella	serovars	identified	
A	 variety	 of	 serovars	 of	 NTS	 have	 currently	 been	 identified	 in	 both	 locations,	with	 some	
overlap	 of	 serovars	 between	 Nairobi	 and	 Busia.	 	 Table	 6	 demonstrates	 the	 isolates	
confirmed	in	each	location	by	whole	genome	sequencing.			
	
Busia	(N=39)	 Both	locations	(N=22)	 Nairobi	(N=22)	
Serovar	 Number	
of	unique	
isolates	
confirmed	
Serovar	 Number	
of	unique	
isolates	
confirmed	
Serovar	 Number	
of	unique	
isolates	
confirmed	
Guildford	
Uganda	
Offa	
Enteritidis	
Newport	
Stanleyville	
Tilene	
Aberdeen	
Bovismorbificans	
5	
3	
2	
1	
8	
3	
1	
1	
1	
Fulica	
(Nairobi	(4),	
Busia	(7)	
Heidelberg	
(Nairobi	(4),	
Busia	(7))	
	
11	
	
	
11		
Typhimurium	
Kiambu	
Virchow	
Braederup	
Anatum	
Muenchen	
Nairobi	
Previously	
untyped	
5	
1	
1	
1	
1	
2	
1	
2	
Table	6.	Demonstrating	the	different	serovars	of	NTS	confirmed	to	be	isolated	from	pig	by	
whole	genome	sequencing	at	each	site.	This	includes	unique	isolates	only,	not	duplicates.		
Negative	NTS	isolates	
As	previously	mentioned,	whole	genome	sequencing	data	has	currently	been	returned	from	
159	of	the	259	isolates	submitted	for	WGS.		A	full	table	of	the	isolates	including	serovar	and	
sequence	type	of	NTS	as	confirmed	by	whole	genome	sequencing	 in	Nairobi	and	Busia,	 in	
addition	 to	 their	 antimicrobial	 resistance	 phenotypes	 as	 measured	 by	 antimicrobial	
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susceptibility	testing,	is	shown	in	the	Appendix	(Table	I).	Of	the	159	which	were	submitted	
for	WGS	results,	87	samples	were	 found	to	be	 isolates	other	 than	NTS.	 	68	of	 these	were	
from	Nairobi	and	19	from	Busia.		These	bacteria	comprised	of	a	range	of	enteric	commensal	
bacteria	 or	 bacteria	 found	 in	 the	environment	 and	 include	Escherichia	 coli,	 Pseudomonas	
aeruginosa,	 Citrobacter	 freundii,	 Proteus	 mirabilis,	 Klebsiella	 pneumoniae,	 Moraxella	
osloensis,	Comamonas	testosteroni,	Cronobacter	sakazakii	and	Enterobacter	cloacae,		
Pending	whole	genome	sequencing	results	
The	 results	of	whole	genome	sequencing	of	100	samples	 (57	 from	Malawi,	28	 from	Busia	
and	15	from	Nairobi)	are	currently	pending.		
Sequence	type	of	NTS	isolates	from	each	site	
A	variety	of	sequence	types	of	S.	enterica	have	been	found	on	whole	genome	sequencing	
(Table	 I,	 Appendix).	 	 One	 isolate	 of	 S.	Typhimurium	 ST313	 and	 four	 unique	 isolates	 of	 S.	
Typhimurium	 ST19	 have	 been	 isolated	 so	 far	 in	 a	 pig	 slaughtered	 in	 Ndumbuini	
slaughterhouse,	 Nairobi,	 Kenya.	 All	 of	 these	 isolates	 have	 susceptible	 antimicrobial	
resistance	phenotypes,	i.e.	resistant	to	fewer	than	three	classes	of	antibiotics.	
Antimicrobial	Susceptibility	Phenotype	of	isolates	
Currently	 the	 antimicrobial	 susceptibility	 phenotype	 only	 is	 available.	 Once	 the	 complete	
results	of	genome	sequencing	have	returned	it	will	be	possible	to	make	a	comparison	of	the	
antimicrobial	 susceptibility	 phenotypes	 with	 the	 antimicrobial	 susceptibility	 genotypes	 of	
each	positive	isolate.		
In	this	case	 ‘susceptible’	antimicrobial	resistance	phenotypes	will	be	defined	as	those	NTS	
isolates	 showing	 antimicrobial	 susceptibility	 phenotypes	 susceptible	 to	 all	 classes	 of	
antibiotics.	Resistant	 isolates	have	been	divided	into	those	isolates	susceptible	to	three	or	
more	antibiotic	classes	and	those	resistant	to	1-2	classes	of	antibiotics.		For	the	purpose	of	
this	 thesis,	 the	 definition	 of	 a	 multi-drug	 resistance	 phenotype	 has	 been	 defined	 as	 ‘a	
bacterial	isolate	resistant	to	three	or	more	different	classes	of	antibiotics’.		
Here	the	antimicrobial	susceptibility	profile	of	unique	isolates	only,	confirmed	to	be	NTS	by	
whole	 genome	 sequencing,	 have	 been	 considered.	 	 As	 no	 WGS	 results	 have	 currently	
returned	 from	 samples	 from	Malawi,	 only	 these	which	 have	 completed	WGS	 from	 Busia	
and	Nairobi	are	discussed	here.		
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	 Busia	(N=39)(%,	95%	CI)	 Nairobi	(N=22)	(%,	95%	CI)	
MDR	 2	(5,	1-17)	 0	
Resistant	to	1-2	antibiotics	 4	(10,	4-24)	 3	(14,	5-33)	
Susceptible	to	whole	panel	 32	(82,	67-91)	 17	(77,	57-90)	
Unmeasured	 1	(3,	0-13)	 2	(9,	3-28)	
Table	 7.	 Antimicrobial	 susceptibility	 profile	 of	 whole	 genome	 sequenced	 unique	 isolates	
from	Nairobi	and	Busia.	
Two	multidrug	resistant	isolates	were	detected	in	samples	from	pigs	from	Busia	(see	Table	
7).	 One	 from	 a	 faecal	 sample,	 serovar	 S.	 Fulica,	 resistant	 to	 ampicillin,	 chloramphenicol,	
ceftazidime,	 ciprofloxacin	 and	 cefotaxime,	 and	 the	 other	 serovar	 S.	 Stanleyville,	 isolated	
from	 a	 mesenteric	 lymph	 node	 with	 an	 AMR	 phenotype	 resistant	 to	 ampicillin,	
streptomycin,	tetracycline,	gentamicin	and	ciprofloxacin	and	cefotaxime	and	trimethoprim	
sulphamethoxazole	 (see	 Table	 8).	 No	 NTS	 isolates	 from	 Nairobi	 which	 have	 undergone	
whole	genome	sequencing	show	multi-drug	resistance	(see	Table	7).		
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Number	
of	
isolates	
NTS	serovar	 Resistance	
Phenotype	
Number	of	
antimicrobial	
classes	
resistant	to	
Faecal	or	
mesenteric	
lymph	
node	
sample	
Location	
of	
sampling	
%	(95%	CI)	of	
antimicrobial	
resistance	phenotype	
of	the	total	number	of	
unique	whole	genome	
sequenced	samples	
from	each	location.		
Busia	N=39	
Nairobi	N=22	
1	 Stanleyville	 amp	tet	 2	 MLN	 Busia	 3%	(0-13%)	
1	 Stanleyville	 amp	strep	
tet	gent	
cipro	ctx	
trim	
7	 MLN	 Busia	 3%	(0-13%)	
1	 Fulica	 amp	chlor	
caz	cipro	
amoxy-
clav	
3	 F	 Busia	 3%	(0-13%)	
1	 Aberdeen	 strep	 1	 MLN	 Busia	 3%	(0-13%)	
1	 Bovismorbificans	 tet	 1	 MLN	 Busia	 3%	(0-13%)	
1	 Heidelberg	 chlor	ctx	 2	 MLN	 Busia	 3%	(0-13%)	
2	 Typhimurium	 strep	tet	 2	 F	 Nairobi	 9%	(3-28%)	
MLN	 Nairobi	
1	 Heidelberg	 kana	 1	 F	 Nairobi	 5%	(1-22%)	
Table	8.	The	proportion	of	different	 resistant	phenotypes	 in	 faecal	and	mesenteric	 lymph	
node	 samples	 confirmed	 as	 NTS	 by	 whole	 genome	 sequencing	 in	 Busia	 and	 Nairobi.	
Amp=ampicillin,	 tet=tetracycline,	 strep=streptomycin,	 gent=gentamicin,	
Cipro=ciprofloxacin,	 ctx=cefotaxime,	 trim=trimethoprim	 sulphamethoxazole,	
chlor=chloramphenicol,	 caz=ceftazidime,	 amoxy-clav=amoxicillin-clavulanic	 acid,	
kana=kanamycin	
No	 important	 difference	 was	 found	 between	 the	 number	 of	 specific	 antimicrobial	
resistance	 susceptibility	 phenotypes	 measured	 by	 disc	 diffusion	 of	 those	 isolates	 fully	
confirmed	NTS	by	whole	genome	sequencing	from	pigs	slaughtered	in	Busia	and	Nairobi	
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(Table	8).	Nine	different	antimicrobial	susceptibility	phenotypes	were	found,	with	only	two	
of	 these,	 both	 S.	 Typhimurium	 were	 found	 to	 be	 resistant	 to	 the	 same	 antibiotics;	
streptomycin	and	tetracycline	(see	Table	8).	
The	 percentage	 of	 the	 total	 unique	 isolates	 which	 have	 undergone	 whole	 genome	
sequencing	 showing	an	antimicrobial	 susceptibility	phenotype	 resistant	 to	each	 individual	
antibiotic	 is	 shown	 in	 Figure	 6.	 	 From	 the	 isolates	 currently	 sequenced	 no	 significant	
difference	has	been	found	between	the	number	of	isolates	resistant	to	each	antibiotic	and	
therefore	 currently	 no	 conclusion	 can	 currently	 be	 drawn	 as	 to	 which	 antibiotic	 or	
antibiotics	show	significantly	higher	phenotypic	levels	of	resistance.	
	
Figure	6.	Percentage	of	total	 isolates	from	Busia	and	Nairobi	exhibiting	resistance	to	each	
antibiotic	(N=61)	(%,	95%	CI)	
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Chapter	4:	Discussion	
Purpose	of	this	study	
The	main	aim	of	 this	 thesis	was	 to	determine	and	compare	 the	prevalence,	 strains	and	
diversity	of	NTS	in	pig	samples	collected	at	post	mortem	from	three	slaughterhouse	sites;	
two	rural	(Busia,	Kenya	and	the	Chikwawa	Valley,	Malawi)	areas	and	one	urban	(Nairobi,	
Kenya)	area.	A	secondary	aim	was	to	determine	and	compare	the	antimicrobial	resistance	
profiles	of	the	NTS	present.		
Results	summary	
i) Serovars	and	sequence	types	of	NTS	detected	
The	 results	 showed	 that	NTS	 is	 carried	by	pigs	 in	 the	mesenteric	 lymph	nodes	 in	Kenya	
and	 Malawi	 and	 excreted	 into	 the	 environment	 in	 the	 faeces.	 A	 variety	 of	 different	
serovars	were	identified	from	pigs	in	Kenya,	including	S.	Enteritidis,	Virchow,	Heidelberg,	
Fulica,	Offa,	Muenchen,	Kiambu,	Braenderup,	Anatum,	Guildford,	 Stanleyville,	Newport,	
Uganda,	Aberdeen,	Bovismorbificans,	and	Tilene.		Of	particular	concern	was	the	discovery	
of	 S.	 Typhimurium	with	 the	 sequence	 type	 ST313	 in	 a	mesenteric	 lymph	 node	 sample	
from	 a	 pig	 slaughtered	 in	 Ndumbuini	 abbatoir,	 Nairobi,	 Kenya	 and	 reared	 in	 Wangige	
area,	 about	 15	minutes	 north	 of	 the	 Ndumbuini	 District.	 This	 sequence	 type	 has	 been	
found	to	be	the	cause	of	invasive	salmonellosis	in	humans	in	sub-Saharan	Africa	(Kingsley,	
2009).	 In	 total	 five	 unique	 isolates	 of	 S.	 Typhimurium	 were	 identified,	 all	 in	 pigs	
slaughtered	 in	 Nairobi,	 Kenya.	 In	 addition	 to	 the	 one	 S.	 Typhimurium	 ST313,	 the	
remaining	four	sequence	types	of	 isolates	of	this	serovar	were	all	ST19,	which	has	been	
found	to	cause	non-invasive	diarrhoeal	disease	in	humans	worldwide	(McClelland,	2001).		
The	whole	 genome	 sequencing	data	of	 159	of	 the	259	 isolates	 submitted	has	 currently	
been	completed.			
ii) Antimicrobial	susceptibility	phenotypes	detected	
The	antimicrobial	 susceptibility	phenotypes	of	 the	completed	whole	genome	sequences	
demonstrated	a	variety	of	profiles,	with	 resistance	measured	 to	a	variety	of	 the	 twelve	
drugs	 tested.	 Two	multi-drug	 resistant	 isolates	 (resistant	 to	more	 than	 three	 classes	 of	
antimicrobials)	 were	 detected	 amongst	 pigs	 in	 Busia,	 Kenya,	 both	 with	 differing	
antimicrobial	 susceptibility	 phenotypes.	 No	 isolates	 of	 NTS	 with	 MDR	 profiles	 were	
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detected	 from	 pigs	 in	 Nairobi.	 	 Interestingly,	 S.	 Typhimurium	 ST313	 in	 humans	 in	 sub-
Saharan	Africa	often	carries	a	multi-drug	resistant	antimicrobial	susceptibility	phenotype,	
for	 example	 S.	 Typhimurium	 ST313	 D23580	 isolated	 in	 Malawi,	 which	 contains	 in	 its	
genome	 a	 composite	 genetic	 element	 encoding	 multi-drug	 resistant	 genes	 (Kingsley,	
2009).	 The	 S.	 Typhimurium	 ST313	 isolate	 detected	 in	 this	 study	 from	 a	 pig	 reared	 in	
Wangige,	 Nairobi	 was	 susceptible	 to	 the	 full	 range	 of	 antimicrobials	 tested	 on	 disc	
diffusion	and	further	investigation	to	compare	this	susceptible	and	ST313	MDR	genomes	
previously	isolated	from	humans	would	be	of	extreme	interest.	
iii) Results	applied	in	the	current	context	
In	the	context	of	existing	research,	these	results	have	demonstrated	for	the	first	time	the	
presence	 of	 S.	 Typhimurium	 ST313	 in	 pigs	 in	 sub-Saharan	 Africa.	 In	 a	 recent	 paper,	
Almeida	et	al.	(2017)	did	find	raw	pork	to	be	a	source	of	S.	Typhimurium	ST313	in	Brazil.		
In	fact,	this	thesis	reports	the	first	instance	that	this	sequence	type	has	been	discovered	
in	any	animal	on	the	African	continent,	therefore	the	findings	of	this	study	are	potentially	
extremely	 important.	 	 The	 discovery	 of	 ST313	 in	 the	 mesenteric	 lymph	 node	 of	 a	 pig	
reveals	the	potential	 for	an	additional	transmission	route	of	this	 invasive	sequence	type	
of	S.	Typhimurium	rather	 than	solely	human-to-human,	as	had	been	previously	 thought	
(Kariuki,	 2006).	 	 Recent	 literature	 has	 leaned	 heavily	 towards	 the	 theory	 of	 a	 soley	
human-to-human	model	of	transmission	of	in	the	invasive	NTS	bacteria;	further	adapted	
towards	an	 invasive	 lifestyle	 in	humans	 than	other	strains	of	NTS	 (Feasey,	2012,	Okoro,	
2012).	This	phenomenon	has	been	characterised	by	genome	degradation;	Kingsley	(2009)	
found	 that	 pseudogene	 formation	 and	 chromosomal	 deletions	 were	 present	 in	 the	
invasive	 S.	 Typhimurium	 ST313,	 in	 comparison	 to	 other	 non-invasive	 S.	 Typhimurium	
genome	sequences,	although	as	experimental	infection	of	poultry	with	D23580	also	leads	
to	 invasive	 infection,	 it	may	be	more	 ‘lifestyle’	 adapted	 than	adapted	 to	a	 specific	host	
(Wigley,	2017).		Therefore,	the	work	of	this	thesis	raises	many	further	questions,	such	as	
whether	the	ST313	strain	carried	by	this	pig	possesses	the	same	genomic	degradation	and	
potentially	 invasive	 nature	 as	 that	 found	 in	 humans,	 and	 if	 not,	whether	 any	 historical	
linkage	 of	 the	 human-isolated	 invasive	 strain	 and	 this	 pig-isolated	 strain	 can	 be	
established.	 	 This	 will	 be	 achieved	 by	 future	 in	 depth	 bioinformatics	 study	 of	 the	 pig-
isolated	S.	Typhimurium	ST313	genome.	
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Diarrhoeal	 and	 invasive	 disease	 caused	 by	 NTS	 serovars	 present	 a	 problem	 in	 the	
developed	 and	 developing	world.	 	 From	2000-2008	NTS,	 largely	 driven	 by	 the	 serovars	
Typhimurium	and	Enteritidis,	caused	the	highest	burden	of	non-invasive	gastrointestinal	
disease	of	all	food-bourne	pathogens	in	the	United	States	of	America;	at	1,000,000	cases	
recorded	per	year	with	380	annual	deaths	 (Centers	 for	Disease	Control	and	Prevention,	
2011).	 	 Most	 commonly	 in	 otherwise	 healthy	 humans,	 NTS	 causes	 self-limiting	 acute	
gastroenteritis,	 however,	NTS	disease	 is	 a	major	 cause	of	 invasive	bacterial	 infection	 in	
humans	 in	 sub-Saharan	 Africa,	 particularly	 amongst	 the	 very	 young	 and	 old,	 and	
concurrently	sick	or	 immunocompromised	humans	of	all	ages.	 	This	 invasive	disease	has	
mostly	been	 found	 to	be	 caused	by	 the	 serovar	 S.	 Typhimurium,	 although	S.	Enteritidis	
does	play	a	role,	and	together	these	serovars	account	for	91%	of	all	invasive	NTS	recorded	
across	sub-Saharan	Africa	(Uche,	2017,	MacLennan,	2013,	Feasey,	2012).	
Generally,	self-limiting	gastroenteritis	in	humans	caused	by	NTS	is	thought	to	be	acquired	
by	consumption	of	animal	food	products,	especially	undercooked	meat,	eggs	and	poultry	
(Mishu,	1994).	Many	serovars	of	NTS	have	a	proven	ability	to	cause	diarrhoeal	disease	in	
humans	often	 following	a	zoonotic	 transmission	route,	 the	most	common	of	which	 is	S.	
Typhimurium	 (Zhang,	 2003).	 S.	 Typhimurium	 ST19	 causes	 ‘classical’	 and	 common	
gastroenteritis	symptoms	in	humans	across	several	continents,	often	associated	with	the	
strains	 LT2,	 SL1344	 and	 DT104	 NCTC13348	 (Kingsley,	 2009,	 McClelland,	 2001,	 Okoro,	
2012,	 Poppe,	 1998).	 	 Carden	 (2003)	 found	 that	 S.	 Typhimurium	 ST19	 often	 causes	 a	
greater	 degree	 of	 cellular	 invasion,	 macrophage	 death	 and	 consequent	 inflammatory	
reaction	in	the	gastrointestinal	tract	than	ST313.	This	correlates	with	the	higher	degree	of	
gastrointestinal	symptoms	observed	with	S.	Typhimurium	ST19	infection	in	humans	than	
S.	Typhimurium	ST313.		The	ability	of	S.	Typhimurium	ST19	to	be	transmitted	zoonotically	
between	animals	and	humans,	particularly	 from	poultry	and	pigs,	has	been	discussed	 in	
numerous	publications	 including	Barrow	 (2012)	and	Parsons	 (2013).	 In	 this	 context,	 the	
finding	of	S.	Typhimurium	ST19	 in	 faecal	and	mesenteric	 lymph	node	samples	of	pigs	 in	
Nairobi	is	of	interest,	and	works	to	further	confirm	its	importance	in	this	context.		
The	 antimicrobial	 susceptibility	 profiles	 of	 the	 NTS	 isolates	 found	 in	 this	 study	 also	
provide	 interesting	results.	 	Multidrug	resistant	 isolates	of	NTS	have	been	discovered	 in	
pigs	 in	 farming	 situations	 in	 higher	 income	 countries	 (Gebreves,	 2005),	 however	 this	
thesis	provides	only	the	second	description,	to	the	author’s	knowledge,	of	the	isolation	of	
multi-drug	 resistant	 isolates	 of	 NTS	 from	 pigs	 in	 Africa	 (the	 first	 published	 by	 Kikuvi,	
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2007).	 	The	multidrug	resistant	phenotype	found	in	the	two	sequenced	isolates	was	not	
identical,	and	further	work	will	be	carried	out	in	the	future	to	investigate	whether	these	
antimicrobial	 resistance	 determinants	 lie	 within	 the	 core	 or	 accessory	 genomes	 of	 S.	
Typhimurium	 and	 therefore	 help	 to	 determine	 the	 potential	 for	 transfer	 of	 the	
antimicrobial	resistance	determinants	between	bacteria.		
Kariuki	(2002)	found	that	NTS	isolated	from	cattle,	chickens	and	pigs	close	to	the	homes	
of	index	human	hospitalised	cases	of	NTS	were	more	likely	to	be	of	a	host-adapted,	non-
zoonotically	 transmitted	 serovar,	 susceptible	 to	 all	 antimicrobials	 tested.	 	 Previously	 a	
multi-drug	 resistant	100-110kb	plasmid	had	been	 thought	 to	 transfer	between	chickens	
and	humans	between	S.	Typhimurium	and	S.	Enteritidis	on	large	scale	commercial	farms	
in	Kenya	(Kariuki,	1996).		Further	bioinformatics	work	to	more	closely	examine	the	whole	
genome	sequences	of	the	S.	Typhimurium	detected	in	this	study	is	needed	to	identify	the	
genes	associated	with	multi-drug	resistance,	as	well	as	the	location	of	these	genes	within	
the	 genome,	 particularly	 whether	 they	 are	 located	 on	 transferable,	 mobile	 genetic	
elements.		
The	hypothesis	of	 this	project	was	 that	 invasive	NTS	was	present	 in	pigs	 suggesting	 the	
potential	 for	an	alternative	transmission	route	for	this	disease	from	animals	to	humans,	
rather	than	solely	human-to-human.		The	finding	that	pigs	in	sub-Saharan	Africa	are	able	
to	carry	S.	Typhimurium	ST313	in	their	mesenteric	lymph	nodes	raises	the	suspicion	that	
zoonotic	 transmission	 may	 be	 possible.	 Furthermore,	 both	 serovars	 Enteritidis	 and	
Bovismorbificans	were	also	isolated	during	this	study,	both	of	which	have	genetic	variants	
associated	 with	 iNTS	 in	 Malawi	 (Bronowski,	 2013,	 Feasey,	 2016).	 	 However,	 more	
research	 needs	 to	 be	 carried	 out	 to	 prove	 this	 hypothesis	 such	 as	 concurrent	 faecal	
sampling	 of	 humans	 who	 were	 in	 contact	 with	 the	 slaughtered	 pigs	 during	 the	 weeks	
prior	 to	 slaughter	 as	 this	 provide	 stronger	 evidence	 to	 prove	 or	 disprove	 the	 theory	 of	
zoonotic	transmission	of	iNTS	in	sub-Saharan	Africa.			
iv) Current	status	of	results	
At	 the	 current	 time,	 in	 total	 259	 isolates	 have	 been	 submitted	 to	 the	 Earlham	
Laboratories	 for	 whole	 genome	 sequencing,	 sequencing	 of	 159	 samples	 has	 been	
completed	and	 sequencing	data	 for	positive	NTS	 isolates	has	been	 returned	 from	72	of	
these	samples.	The	remaining	87	samples	were	negative	for	NTS.		
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The	project	was	conducted	with	the	objective	that	NTS	isolates	would	be	confirmed	to	be	
NTS	 once	 the	 sequencing	 results	 had	 returned.	 	 All	 of	 the	 Malawi	 isolates	 have	 been	
submitted	 for	 sequencing	 based	 on	 a	 positive	 selective	 culture	 result	 and	 positive	
agglutination	 test	 with	 the	 Poly-O	 antigen	 alone	 (see	 Figure	 5;	 Results).	 	 Of	 the	 159	
isolates	 for	which	 the	WGS	results	have	already	 returned,	87	 (54.7%)	were	 found	 to	be	
not	NTS,	 or	 there	was	 no	 growth	within	 the	 samples.	 	 Given	 this	 high	 rate	 of	 negative	
isolates	gained	on	WGS,	and	that	samples	submitted	for	whole	genome	sequencing	have	
a	 45.3%	 likelihood	 to	 be	NTS,	 results	 of	 prevalence	 and	 the	 antimicrobial	 susceptibility	
profile	currently	are	reported	for	confirmed	isolates	only.			
v) Limitations	of	study	design	
Estimated	sample	size	calculations	had	provided	an	estimate	of	appropriate	sample	size	
for	 the	project	 to	 reach	154	pigs	per	study	site.	 	This	 figure	was	achieved	 in	both	Busia	
and	Nairobi.		However,	due	to	delays	in	obtaining	in	country	ethical	approval	for	Malawi,	
the	sampling	time	was	reduced	to	a	total	of	two	weeks	in	this	county	and	therefore	only	
65	pigs	were	sampled.	Pigs	are	reared	in	a	low	intensity	fashion	in	the	Chikwawa	Valley,	
where	slaughter	of	pigs	occurs	 infrequently	according	 to	demand.	 	Fewer	 than	 five	pigs	
were	slaughtered	in	each	village	daily	and	it	was	therefore	not	logistically	possible	for	the	
target	 sample	 size	 of	 154	 pigs	 to	 be	met	 in	 this	 time	 period.	 	 Therefore,	 although	 the	
sequencing	results	for	Malawi	will	be	taken	into	consideration	following	their	completion,	
this	part	of	this	study	will	not	be	adequately	powered	to	establish	significant	conclusions	
using	this	data.		
The	sampling	 strategy	 in	Malawi	and	Kenya	presented	challenges	which	could	not	have	
been	forseen	prior	to	the	start	of	the	project.	In	Malawi,	particularly	the	Chikwawa	Valley,	
the	free-ranging	pigs	are	slaughtered	in	the	backyard	of	the	owners,	prior	to	transport	of	
the	 exposed	 carcass	 on	 the	 back	 of	 a	 bicycle	 to	 the	 market	 butchery.	 This	 occurs	 as	
followers	 of	 the	 Islamic	 faith	 consider	 pigs	 to	 be	 impure	 animals	 and	 therefore	 the	
location	of	rearing	and	slaughter	should	be	separate	from	that	of	cattle,	sheep	and	goats.		
Although	 the	 Islam	 is	 followed	 by	 a	minority	 of	 the	 population	 in	Malawi,	 this	 cultural	
belief	has	influenced	the	practise	of	porcine	slaughter	in	this	country.		This	increased	the	
difficulty	of	sample	collection	during	this	project.		Animal	Meat	Inspectors	(one	working	in	
each	of	the	eleven	Extension	Planning	Areas	of	the	Chikwawa	District)	were	on	occasion	
able	to	be	alerted	to	the	location	of	slaughter	of	a	pig	in	the	hours	prior	to	slaughter	by	
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slaughter	men,	and	were	therefore	able	to	alert	the	author	that	samples	were	ready	to	be	
collected.	 	However,	 if	 this	did	not	happen	and	the	 location	of	 slaughter	was	unknown,	
sample	 collection	 relied	 on	 the	 owner	 or	 Trader	 of	 the	 pig	 remembering	 to	 bring	 the	
mesenteric	 lymph	 nodes	 and	 faecal	 sample	 to	 the	 butchery	 for	 collection.	 	 Although	
lessons	in	sampling	technique	were	given	to	pig	owners	and	Traders	where	possible	prior	
to	the	onset	of	the	study,	it	could	not	be	guaranteed	that	samples	were	collected	by	the	
slaughter	 men	 hygienically	 and	 without	 contamination.	 In	 both	 study	 sites	 in	 Kenya	
sample	 collection	 was	 able	 to	 be	 undertake	 either	 by	 the	 author,	 or	 by	 trained	
fieldworkers	 supervised	 by	 the	 author,	 therefore	 in	 these	 cases	 hygienic	 and	 sanitary	
sample	collection	was	able	to	take	place,	and	contamination	therefore	minimised.		
Should	the	study	be	extended	or	repeated,	ethical	permission	to	undertake	faecal	sample	
collection	 from	 human	 slaughterhouse	 workers	 or	 pig	 owners	 who	 are	 regularly	 in	
contact	 with	 pigs	 would	 be	 obtained	 and	 these	 samples	 would	 be	 collected	
simultaneously	with	 the	pig	 faecal	 sample	collection.	 	The	 lack	of	corresponding	human	
data	in	this	study	means	that	the	conclusion	that	serovars	of	NTS	with	zoonotic	potential	
were	 affecting	 pigs	 is	 an	 assumption	 only,	 as	 there	 is	 no	 direct	 evidence	 that	 zoonotic	
transmission	of	disease	has	taken	place	at	any	of	the	study	sites.			
The	 antimicrobial	 susceptibility	 profiles	 of	 some	 isolates	 were	 incomplete.	 This	 was	
minimised	as	much	as	possible,	but	the	antimicrobial	disc	for	kanamycin	was	unavailable	
for	testing	 in	Busia.	 	Therefore,	an	alternative	aminoglycoside,	gentamicin,	was	 included	
in	 the	 disc	 diffusion	 protocol	 instead.	 	 Although	 gentamicin	 and	 kanamycin	 are	 both	
broad-spectrum	antibiotics	of	the	aminoglycoside	family,	 it	was	not	expected	that	there	
would	be	cross-over	between	the	antimicrobial	susceptibility	phenotypes	which	the	NTS	
found	in	the	pigs	displayed	to	these	antibiotics.		
Due	 to	 the	 cross-sectional	 nature	of	 the	project,	 sampling	was	 carried	out	 at	 the	 three	
study	 sites	 at	 different	 times	 of	 year	 which	 may	 have	 affected	 the	 results	 due	 to	
variations	in	seasonality.		However,	this	was	impossible	to	control	for	due	to	the	scope	of	
the	project	prohibiting	repeat	or	simultaneous	sampling	at	the	study	sites.				
Collection	 of	 the	 faecal	 and	 mesenteric	 lymph	 node	 samples	 at	 the	 slaughterhouses,	
slaughter	slabs	and	butcheries	normally	prohibited	contact	with	the	owner	of	the	pigs.	On	
the	day	of	slaughter,	pigs	in	Kenya	and	Malawi	are	bought	from	their	original	owner	by	a	
Trader,	 who	 takes	 the	 pigs	 to	 the	 assigned	 location	 where	 slaughter	 will	 take	 place.	
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Therefore,	it	was	not	possible	to	obtain	exact	GPS	co-ordinates	for	the	location	where	the	
pigs	were	 reared,	 and	precise	details	 for	metadata	 such	as	 age	of	 the	pig	 and	previous	
antimicrobial	treatment	were,	in	most	cases,	impossible	to	obtain	as	the	Traders	were	not	
aware	of	this	information.	Had	there	been	time	and	resources	available,	visits	would	have	
been	paid	to	the	location	described	by	the	Traders	where	the	pigs	had	been	reared	and	
an	 interview	with	 an	 owner	 of	 the	 pig	would	 have	 been	undertaken	 to	 ascertain	more	
precise	metadata.			
‘Duplicate’	isolates	in	this	project	referred	to	isolates	of	NTS	from	the	same	tissue	of	the	
same	pig	detected	on	both	modified	brilliant	green	agar	and	Harlequin	chromogenic	agar	
(Lab	M,	Bury,	UK),	with	identical	serovars	and	sequence	types	as	detected	from	analysis	
of	the	MLST	results	and	AMR	profiles.	Some	modified	brilliant	green	agar	and	Harlequin	
chromogenic	agar	 isolates	from	the	same	tissue	of	the	same	pig	did	present	differences	
(e.g.	 Table	 4;	 Results).	 This	 suggests	 that	 individual	 pigs	 in	 this	 study	 could	 potentially	
either	 be	 carrying	multiple	 strains	 of	NTS,	 and	 during	 this	 study	 two	 of	 these	 different	
strains	were	detected	one	on	each	of	the	agars.	 In	this	study,	only	one	pick	per	plate	of	
NTS	was	taken;	to	improve	the	reliability	of	this	statement,	multiple	picks	per	plate	would	
have	been	taken	to	confirm	the	diversity.		Evidence	of	one	pig	carrying	multiple	strains	of	
strains	of	NTS	is	also	suggested	by	the	presence	of	several	pigs	in	the	study	with	different	
isolates	detected	in	the	mesenteric	lymph	nodes	and	faeces.		Further	work	in	the	future	
to	determine	the	likelihood	of	both	these	situations	would	be	of	interest.	
Pigs	 in	the	three	study	sites	 in	sub-Saharan	Africa	carry	a	variety	of	potentially	zoonotic	
NTS	serovars	in	the	mesenteric	lymph	nodes	as	well	as	excreting	them	in	faeces.	There	is	
the	potential	for	these	zoonotic	serovars	to	transmit	to	humans,	either	through	fomites	in	
the	environment,	or	contamination	of	meat	processing	at	slaughterhouses,	butcheries	or	
a	household	level.	Therefore,	pigs	have	the	potential	to	transmit	several	serovars	of	NTS	
to	and	from	humans.		
vi) Antimicrobial	Resistance	
The	 most	 commonly	 used	 antimicrobials	 in	 humans	 in	 Kenya	 include	 doxycycline,	
tetracycline	 and	 co-trimoxazole	 as	 reported	 by	 Kariuki	 (Global	 Antimicrobial	 Resistance	
Partnership,	2011,	taken	from	the	importation	licences	and	manufacturers’	records	at	the	
Poisons	 and	 Pharmacy	 Board	 and	 the	 Ministry	 of	 Trade	 (Mitema,	 2004)).		
Chloramphenicol	usage	was	documented	as	high	 in	humans	as	 this	drug	was	commonly	
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used	to	treat	NTS	and	Typhoid	fever.	Fluoroquinolone	and	aminoglycoside	use	markedly	
increased	between	the	period	of	1997-1998	after	the	release	of	generic	forms	of	the	drug	
to	 the	 market	 (Mitema,	 2004)	 and	 the	 emergence	 of	 resistance	 to	 chloramphenicol	
(Gordon,	 2008).	 	 Mitema	 (2004)	 found	 that	 first	 generation	 cephalosporins	 were	 in	
greater	use	at	this	time	than	those	of	the	second	and	third	generation.		Worryingly,	half	
of	medicines	 in	Africa	 are	 used	 irrationally	 (Ecumenical	 Pharmaceutical	Network,	 2009)	
and	 antibiotics	 are	 freely	 available	 to	 treat	 both	 humans	 and	 animals	 without	
prescription,	therefore	patterns	of	dispensing	for	identical	illnesses	will	vary,	and	may	not	
always	necessarily	be	appropriate	or	 representative.	 The	pricing	of	 antibiotics	may	also	
play	some	role	in	the	decision	of	which	drug	to	use	to	treat	an	ill	human	or	animal	and	in	
Kenya	or	Malawi	it	does	not	always	follow	that	the	broader	spectrum	antibiotics	are	the	
most	 expensive.	 	 Therefore,	 a	 patient	 or	 livestock	 owner’s	 economic	 situation	may,	 by	
necessity,	 influence	 the	 antibiotic	 treatment	 of	 choice	 to	 a	 greater	 degree	 than	
consideration	 of	 appropriate	 antimicrobial	 stewardship	 principles.	 	 In	 Kenya,	 it	 has	
previously	 been	 found	 that	 antibiotics	 such	 as	 the	 tetracyclines,	 penicillins,	
sulphonamides,	 gentamicin	 and	 chloramphenicol	 are	 dispensed	 by	 70%	 of	 farmers	
without	 prescription	 in	 an	 unregulated	manner	 for	 growth	 promotion,	 prophylaxis	 and	
treatment	 (Kariuki,	 1997).	 	 However,	 practises	 may	 have	 changed	 over	 time	 since	 the	
publication	of	this	paper.		For	example,	from	subjective	observations,	we	are	aware	that	
currently	streptomycin	is	used	more	often	by	farmers	for	their	animals	than	gentamicin.		
It	has	been	speculated	that	some	farmers	have	been	found	to	be	more	reliant	on	the	use	
of	antibiotics	for	raising	good	quality	animals,	rather	than	the	implementation	of	proper	
feeding	practices	or	husbandry	protocols.		Adelaide	(2008)	detected	a	high	percentage	of	
antimicrobial	resistant	E.	coli	 isolates	 in	chickens	at	a	processing	plant	 in	Limuru,	Kenya;	
75.9%	of	isolates	showed	an	antimicrobial	resistance	phenotype	resistant	to	tetracycline,	
39%	 to	 ampicillin,	 13.2%	 to	 chloramphenicol,	 72.4%	 to	 co-trimoxazole	 and	 19%	 to	
ciprofloxacin	where	antibiotics	were	regularly	used	as	prophylaxis.	Kikuvi	(2007)	detected	
35.7%	 antimicrobial	 resistance	 from	 a	 small	 sample	 size	 of	 16	NTS	positive	 pigs.	 These	
NTS	 isolates	 showed	 various	 AMR	 phenotypes,	 including	 antimicrobial	 resistance	 to	
ampicillin,	chloramphenicol,	streptomycin	and	tetracycline,	encoded	by	the	genes	catAI,	
strA	and	tet(A),	respectively.			
In	 this	 study,	 although	 there	 was	 minimal	 difference	 between	 the	 percentage	 of	 the	
unique	 isolates	 detected	 in	 Kenya,	 which	 show	 antimicrobial	 resistance	 to	 different	
antibiotics,	ampicillin	(4.9%,	CI	1.7-13.5),	tetracycline	(8.2%,	CI	3.6-17.8)	and	streptomycin	
	 64	
(6.6%,	CI	2.6-15.7)	 showed	a	higher	percentage	of	 resistance	 than	 the	other	nine	drugs	
included	in	the	panel.	This	correlates	with	the	high	percentage	resistance	to	these	drugs	
detected	 in	chickens	 in	Limuru	 (Adelaide,	2008)	and	 the	 resistant	antibiotic	phenotypes	
detected	by	Kikuvi’s	study	(2007).			
Musicha	(2017)	has	published	surveillance	data	of	antibiotic	resistance	as	detected	in	the	
Queen	 Elizabeth	 Central	 Hospital,	 Blantyre,	 Malawi	 from	 1998-2016.	 	 194,539	 blood	
culture	samples	were	tested	and	29,183	pathogens	were	 isolated	over	this	 time	period.	
51.1%	 of	 these	 were	 resistant	 to	 the	 first-line	 antibiotics	 used	 in	 Malawi;	 penicillin,	
chloramphenicol	 and	 co-trimoxazole.	 The	 proportion	 of	 non-Salmonellae	
Enterobacteriaceae	 with	 resistance	 to	 third	 generation	 cephalosporins	 and	
fluoroquinolones	rose	throughout	the	study	period	to	61.9%	in	2016.	This	is	an	extremely	
high	level	of	resistance	and	close	attention	will	be	paid	to	the	AMR	profiles	of	any	positive	
NTS	 isolates	 in	 pigs	 from	 Malawi	 to	 detect	 whether	 there	 is	 correlation	 between	 the	
human	and	animal	data.		
vii) Implications	of	this	study	
Knowledge	of	the	diverse	range	of	zoonotic	serovars	of	NTS	carried	and	excreted	by	pigs	
in	the	study	sites	raises	particular	concern	for	 the	potential	 risk	which	pigs	may	pose	 in	
the	zoonotic	transmission	of	this	bacteria.	Pigs	in	rural	areas	of	Kenya	and	Malawi	are	free	
roaming	and	so	have	access	to	human	faeces	to	eat,	as	well	as	the	potential	to	defecate	
within	easy	access	of	humans,	including	children.	Pigs	reared	in	more	commercial,	urban	
environments,	 such	 as	 some	 of	 the	 animals	 slaughtered	 at	 Ndumbuini	 slaughterhouse,	
Nairobi,	also	live	in	close	proximity,	therefore	the	frequent	contact	between	the	animals	
within	a	herd	increases	the	risk	of	transmission	of	these	bacteria	between	them.		
Zoonotic	 transmission	 of	 the	 bacteria	 to	 humans,	 depending	 on	 the	 serovar,	 sequence	
type	 and	 strain,	 may	 lead	 to	 mild,	 self-limiting	 gastroenteritis,	 as	 reported	 in	 several	
studies,	caused	by	serovars	discovered	in	faeces	or	mesenteric	lymph	nodes	of	pigs	in	this	
study,	or	potentially	more	 invasive,	debilitating	disease,	particularly	amongst	those	who	
are	concurrently	ill	or	immune	compromised.		Invasive	disease	can	be	caused	in	humans	
by	 sequence	 type	 ST313,	 found	 in	 humans	 in	 sub-Saharan	 Africa,	 and	 never	 previously	
identified	in	pigs	on	this	continent.		The	identification	in	this	study	of	one	S.	Typhimurium	
ST313	 strain	 in	 the	 mesenteric	 lymph	 node	 in	 a	 pig	 slaughtered	 in	 Ndumbuini	
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slaughterhouse,	 Nairobi,	 raises	 concerns	 that	 pigs	 may	 be	 implicated	 in	 the	 zoonotic	
spread	of	this	bacteria,	and	further	work	needs	to	be	performed	to	confirm	this.		
Practical	 applications	 of	 the	 results	 of	 this	 study	 differ	 varying	 on	 the	 environment	 in	
which	the	pigs	are	reared.	In	some	counties	and	districts	in	Kenya	and	Malawi,	free	range	
pig	production	has	been	outlawed.		This	is	not	the	case	in	Busia	County	or	the	Chikwawa	
Valley.	Implementation	of	this	by-law	would	limit	the	access	of	pigs	to	human	faeces	for	
consumption	of	waste	contaminated	with	NTS	serovars,	and	limit	the	contact	of	humans	
to	porcine	 faeces,	 the	disposal	of	which	could	be	more	hygienically	managed	 in	a	more	
contained	 environment.	 Hygiene	 considerations	 should	 also	 be	 reviewed	 in	 more	
intensive	pig-rearing	facilities	in	Kenya,	from	which	some	of	the	samples	from	Ndumboini	
slaughterhouse	 originated.	 	 This	 would	 include	 appropriate	 protection	 and	 personal	
hygiene,	such	as	washing	hands	for	the	stockmen	handling	the	pigs,	and	a	clear	hygiene	
and	sanitation	policy	and	protocol	for	controlling	the	mixing	of	pigs.	The	aim	of	this	would	
be	 to	 limit	 the	 spread	 of	 potentially	 zoonotic	 bacteria	 and	 transfer	 of	 antimicrobial	
resistance	determinants.		
viii) Recommendations	for	further	research	
The	results	of	this	study	will	be	expanded	once	all	 isolates	submitted	for	whole	genome	
sequencing	 have	 completed	 their	 processing.	 	 This	 will	 enable	 a	 full	 picture	 of	 the	
prevalence	 of	 NTS	 and	 diversity	 of	 serovars,	 sequence	 types	 and	 antimicrobial	
susceptibility	 genotypes	 to	be	 ascertained.	 The	 current	 results	 provide	baseline	data	of	
the	more	prevalent	serovars	of	NTS	detected	in	the	pigs.	
There	 are	 numerous	 extensions	 of	 this	 study	 which	 would	 be	 of	 extreme	 interest.	 A	
natural	subsequent	study	would	involve	collecting	retrospective	human	data	of	previously	
identified	NTS	infections	from	the	same	area	that	the	pigs	were	reared	or	slaughtered	in	
order	to	make	a	comparison	between	the	nature	of	the	NTS	isolated	from	pigs	during	this	
study	and	that	of	humans	 in	the	same	area.	A	 further	extension	would	be	sampling	the	
stools	 of	 pigs	 and	 their	 owners,	 farm	 workers	 and	 the	 slaughterhouse	 workers	
simultaneously.	 This	 would	 help	 to	 ascertain	 whether	 both	 humans	 and	 pigs	 carry	
identical	 isolates	 of	 NTS,	 and	 so	 investigate	 the	 potential	 for	 zoonotic	 transmission	 in	
these	environments	 in	Kenya	and	Malawi.	 	 Surveillance	of	 febrile	or	diarrhoeic	patients	
admitted	to	hospital	with	confirmed	NTS	infection	would	also	be	informative.	Sampling	of	
in-contact	 humans	 and	 animals	 at	 the	 household	 of	 the	 patient,	 to	 ascertain	 whether	
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human-to-human	 or	 zoonotic	 transmission	 had	 occurred,	 would	 provide	 evidence	 to	
determine	 whether	 transmission	 of	 NTS	 by	 pigs	 or	 other	 in	 contact	 animals	 at	 a	
household	level	had	the	potential	to	lead	to	clinical	disease	in	humans.		
Antimicrobial	usage	data	 for	both	humans	and	pigs	 from	areas	where	pigs	were	 reared	
and	slaughtered	 in	this	study	would	have	been	useful	 to	put	the	results	 into	context.	 In	
this	 survey,	 the	 Traders	who	 brought	 the	 pigs	 to	 the	 slaughterhouse	were	 unaware	 of	
previous	treatment	which	had	been	administered	to	the	pigs,	either	name	of	drug,	dose	
or	frequency,	and	this	information	would	have	been	extremely	useful	to	assess	previous	
exposure	of	the	pigs	to	antimicrobial	drugs.	From	subjective	observations,	we	know	that	
the	 most	 commonly	 used	 antimicrobials	 in	 the	 study	 sites	 are	 generally	 ampicillin,	
tetracycline	 and	 streptomycin,	 and	 this	 is	 realised	 in	 the	 results	 seen	 in	 this	 project	 as	
these	 are	 the	most	 common	 antimicrobials	 for	 which	 resistance	was	 found	 in	 the	NTS	
isolates	 cultured.	 This	 suggests	 that	 there	 is	 transfer	 of	 antimicrobial	 resistance	
determinants	at	some	level	of	the	population	between	the	pigs	and	the	humans,	although	
the	exact	route	of	this	transfer	is	not	yet	known.		Further	study	of	interactions	between	
the	 species	 at	 a	 household	 and	 village	 level	 would	 help	 us	 to	 understand	 to	 the	
movement	of	antimicrobial	resistance	determinants	through	a	population,	and	therefore	
assist	 in	 the	 limiting	 this	 spread.	 	 If,	 as	 the	 Traders	 mostly	 suspected	 on	 questioning,	
antimicrobial	treatment	in	pigs	is	a	rare	event,	the	antimicrobial	resistance	determinants	
present	 in	 the	 NTS	 carried	 and	 excreted	 by	 the	 pigs	must	 either	 arise	 by	 spontaneous	
mutation,	or	more	likely	having	been	acquired	from	an	outside	source,	therefore	it	would	
be	 extremely	 useful	 to	 determine	 whence-forth	 these	 determinants	 came.	 	 One	 other	
factor	which	would	be	 interesting	 to	assess	 is	 the	 change	 in	 antimicrobial	 susceptibility	
patterns	 in	 NTS	 isolated	 from	 pigs	 in	 the	 field	 over	 time.	 	 However,	 this	 study	 would	
present	challenges	to	perform	in	field	conditions,	owing	to	the	low	intensity	nature	of	pig	
farming	in	both	Busia	and	Malawi,	and	the	difficulty	in	repeat	sampling	of	identical	pigs	in	
the	field.				
ix) Conclusions	
This	 study	 shows	 that	 pigs	 at	 slaughter	 in	 Busia	 and	 Nairobi,	 Kenya	 and	 the	 Chikwawa	
Valley,	Malawi	carry	a	variety	of	NTS	serovars	with	assorted	AMR	profiles,	 including	MDR	
phenotypes.	 There	 is	 the	 potential	 for	 zoonotic	 transmission	 of	 NTS	 between	 pigs	 and	
humans	in	Kenya	and	Malawi	and	the	transfer	of	AMR	determinants	between	these	species	
should	be	considered.	
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Appendix	
Contents	of	Appendix	
Page	Number	 Table	or	Map	number	 Table	or	map	heading	
Page	97-103	 Table	I	 Complete	table	of	all	
positive	NTS	isolates	
returned	from	sequencing	
Page	94	 Map	I	 Location	of	slaughterslabs	
in	Busia	county	
	
Page	95	 Map	II	 Location	of	rearing	of	NTS	
positive	pigs	sampled	in	
Busia	
Page	96	 Map	III	 Locations	of	sample	
collection	in	the	Chikwawa	
Valley,	Malawi	
Page	97	 Map	IV	 Locations	of	rearing	of	NTS	
positive	pigs	sampled	in	
Ndumbuini	slaughterhouse,	
Nairobi	
Page	98	 Map	V	 Location	of	rearing	of	NTS	
positive	pigs	sampled	
around	Nairobi	
	
Table	1	shows	the	complete	results	of	all	positive	 isolates	of	NTS	currently	 returned	from	
whole	genome	sequencing.	The	majority	of	this	 isolates	are	 ‘unique’	 isolates,	 i.e.	 they	are	
single	 isolates	 of	 NTS	 which	 originate	 from	 pigs	 and	 hold	 differing	 antimicrobial	
susceptibility	 phenotypes,	 serovars	 and	 sequence	 types	 from	 the	 other	 all	 other	 isolates	
determined,	even	from	other	isolates	found	within	the	same	pig.	Within	this	table	there	are	
also	11	duplicate	isolates	included.	These	duplicates	are	two	isolates	which	originate	from	
the	same	pig,	 found	in	the	same	location	(either	mesenteric	 lymph	node	or	faecal	sample	
	 96	
pig)	 as	 another	 and	 share	 the	 same	 serovar,	 sequence	 type	 and	 antimicrobial	 resistance	
profile;	 therefore	for	the	purpose	of	this	study	they	are	considered	 identical.	One	of	each	
duplicate	 isolate	 of	 each	 pair	 has	 been	 highlighted	 in	 bold	 in	 the	 table	 for	 ease	 of	
identification.		
Map	 data	 shows	 the	 locations	 of	 slaughterslabs	 and	 sample	 collection	 In	 Busia	 (Map	 I),	
Chikwawa	Valley	(Map	III).	Map	II	and	Map	IV	show	the	location	of	pigs	reared	from	which	
samples	were	collected	in	Busia	and	Nairobi.	The	location	of	rearing	of	pigs	in	Malawi	was	
not	able	to	be	determined	during	sample	collection.		
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63	 298	
FD01543
516	 Busia	 12mo	 white	 m	 Bumala	 Bumala	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	
	
	
Newport	 46	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
63	 318	
FD01543
553	 Busia	 12mo	 white	 m	 Bumala	 Bumala	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Newport	 46	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	
72	 308	
FD01844
672	 Busia	 5-6mo	 black	
unkno
wn	 Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Stanleyville	
198
6	 MDR	 R	 S	 R	 R	 R	 		 S	 S	 R	 R	 R	 I	
72	 319	
FD01543
545	 Busia	 5-6mo	 black	
unkno
wn	 Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Stanleyville	 912	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
75	 299	
FD01543
508	 Busia	 14mo	 white	 f	 Siteko	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Guildford	
428
8	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	
76	 219	
FD01543
589	 Busia	 6mo	 white	 f	
Kubringa
la,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
F	
HA
C	 n	 y	 y	 Guildford	
428
8	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 		
81	 301	
FD01844
601	 Busia	 6mo	 white	 m	
Nwamon
ge,	
Bumala	 Bumala	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Heidelberg	 15	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
83	 303	
FD01844
593	 Busia	 9mo	 black	 f	
Eburiang
,	Sikulu	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Fulica	
106
3	 Susceptible	 s	 s	 i	 s	 s	 s	 s	 s	 s	 s	 s	 s	
83	 304	
FD01543
557	 Busia	 9mo	 black	 f	
Eburiang
,	Sikulu	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 Y	 y	 Y	 Fulica	
106
3	 Susceptible	 s	 s	 i	 s	 s	 s	 s	 s	 s	 s	 s	 s	
85	 290	
FD01543
533	 Busia	 12mo	 black	 m	
Sirisia,	
Bugengi	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
85	 291	
FD01543
524	 Busia	 12mo	 black	 m	
Sirisia,	
Bugengi	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 No	serovar	 ND	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
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86	 293	
FD01543
588	 Busia	 10mo	
black	
and	
white	 m	
Mudoko
mi,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	
No	
Salmonella	
identified	 ND	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
86	 305	
FD01543
549	 Busia	 10mo	
black	
and	
white	 m	
Mudoko
mi,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
97	 288	
FD01543
564	 Busia	 6mo	 white	 f	
Mabung
e,	
Nambale	 Nambale	
Motorb
ike	
Unkno
wn	
LN	
HA
C	 Y	 y	 Y		 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
11
3	 295	
FD01543
541	 Busia	 7mo	
unkno
wn	 m	
Mohuyu,	
Kisoko	 Mugatsi	
Motorb
ike	
Treate
d,	
unsure	
what	
or	
when	
ML
N	
BG
A	 y	 y	 y	 Offa	
-
319	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
11
6	 221	
FD01543
542	 Busia	 18mo	 white	 f	
Kagina,	
Bujumba	 Bumala	
Motorb
ike	
Treate
d	1	
month	
ago,	
unkno
wn	
drug	
F	
BG
A	 y	 y	 y	 Heidelberg	
429
2	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 		
11
6	 279	
FD01543
563	 Busia	 18mo	 white	 f	
Kagina,	
Bujumba	 Bumala	
Motorb
ike	
Treate
d	1	
month	
ago,	
unkno
wn	
drug	
ML
N	
BG
A	 y	 y	 y	 Heidelberg	
429
2	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
12
1	 286	
FD01543
556	 Busia	
Unkno
wn	
unkno
wn	
unkno
wn	
Unknow
n	 Unknown	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Enteritidis	 11	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	
14
0	 270	
FD01543
522	 Busia	 9mo	 white	 m	
Buringal
a,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Newport	 46	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
14
0	 277	
FD01543
579	 Busia	 9mo	 white	 m	
Buringal
a,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Newport	 46	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 I	 I	 S	 S	 S	
14
4	 276	
FD01543
555	 Busia	 9mo	
black	
and	
white	 f	
Buyende
,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Uganda	 684	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
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14
4	 287	
FD01543
548	 Busia	 9mo	
black	
and	
white	 f	
Buyende
,	
Mundika	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 Y	 Uganda	 684	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 I	 S	 S	 S	
14
6	 269	
FD01543
531	 Busia	 5mo	
black	
and	
white	 m	 Mundika	 Mundika	
motorb
ike	
Unkno
wn	
F	
BG
A	 y	 y	 y	 Uganda	 684	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 I	 S	 S	 S	
14
6	 273	
FD01543
539	 Busia	 5mo	
black	
and	
white	 m	 Mundika	 Mundika	
motorbi
ke	
Unkno
wn	
F	
HA
C	 y	 y	 y	 Uganda	 684	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
15
5	 167	
FD01844
631	 Busia	 6mo	
unkno
wn	 m	 Bugenyi	 Mundika	
Motorb
ike	
Unkno
wn	
F	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 I	 I	 S	 S	 S	
15
5	 168	
FD01844
639	 Busia	 6mo	
unkno
wn	 m	 Bugenyi	 Mundika	
Motorb
ike	
Unkno
wn	
F	
BG
A	 y	 y	 Y	 Fulica	
106
3	 MDR	 R	 R	 S	 S	 S	 		 I	 R	 R	 R	 S	 R	
15
5	 241	
FD01543
532	 Busia	 6mo	
unkno
wn	 m	 Bugenyi	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Heidelberg	 15	
Resistant	to	
chloramphe
nicol	and	
cefotaxime	 S	 R	 I	 S	 S	 S	 S	 S	 S	 R	 S	 I	
17
9	 243	
FD01543
540	 Busia	 8mo	
unkno
wn	 f	 Bumala	 Bumala	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Heidelberg	 15	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
18
9	 257	
FD01543
527	 Busia	 12mo	
unkno
wn	 f	 Sikulu	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Aberdeen	
403
8	 Susceptible	 S	 S	 R	 S	 S	 S	 S	 S	 I	 S	 S	 S	
20
2	 200	
FD01543
581	 Busia	 24mo	
unkno
wn	
unkno
wn	 Funyula	 Funyula	
Motorb
ike	
Unkno
wn	
F	
HA
C	 y	 y	 y	 Uganda	 684	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	
21
2	 233	
FD01543
582	 Busia	 6mo	 white	 f	
Lwanikh
a,		 Nambale	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 		
25
3	 133	
FD01844
663	 Busia	 12mo	
black	
and	
white	 f	
Busibwa
bo	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	
Bovismorbifi
cans	 142	
Resistant	to	
streptomyci
n	and	
tetracycline	 S	 S	 i	 R	 S	 S	 S	 S	 S	 S	 S	 S	
25
5	 124	
FD01543
536	 Busia	 6mo	 black	 f	
Sirisia,	
Bugengi	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y		 Tilene	 912	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
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25
5	 127	
FD01844
584	 Busia	 6mo	 black	 f	
Sirisia,	
Bugengi	 Mundika	
Motorb
ike	
Unkno
wn	
ML
N	
HA
C	 Y	 y	 Y	 Tilene	 912	 Susceptible	 s	 s	 s	 s	 s	 s	 s	 s	 s	 s	 s	 s	
25
7	 157	
FD01844
671	 Busia	 12mo	
unkno
wn	 m	
Logingo,	
Matayos	 Bumala	
Motorb
ike	
Unkno
wn	
F	
BG
A	 y	 y	 y	 Newport	 166	 Susceptible	 S	 S	 I	 S	 S	 		 S	 S	 I	 S	 S	 S	
26	 15	
FD01543
546	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Dandora	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
31	 340	
FD01844
616	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Ruiru	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
BG
A	 y	 y	 y	 Muenchen	 82	 Susceptible	 S	 S	 I	 S	 S	 		 S	 S	 S	 S	 S	 S	
35	 349	
FD01543
561	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Githung
uri	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
BG
A	 y	 y	 y	 Muenchen	 82	 Susceptible	 S	 S	 I	 S	 S	 		 S	 S	 I	 S	 S	 S	
35	 379	
FD01543
499	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Githung
uri	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
HA
C	 y	 y	 y	 Muenchen	 82	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	
66	 352	
FD01844
613	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 m	 Githiga	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
70	 353	
FD01543
506	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 m	
Unknow
n	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
BG
A	 y	 y	 Y	
Typhimuriu
m	 19	 No	results	 		 		 		 		 		 		 		 		 		 		 		 		
71	 360	
FD01844
653	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 f	
Unknow
n	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
BG
A	 y	 y	 y	
Typhimuriu
m	 19	
Resistant	to	
streptomyci
n	and	
tetracycline	 S	 S	 R	 R	 S	 S	 S	 S	 S	 S	 S	 S	
71	 361	
FD01844
673	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 f	
Unknow
n	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
HA
C	 y	 y	 y	
Typhimuriu
m	 19	
Resistant	to	
streptomyci
n	and	
tetracycline	 S	 S	 R	 R	 S	 		 S	 S	 S	 S	 S	 S	
94	 323	
FD01844
661	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Banana	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Kiambu	 309	 Susceptible	 S	 S	 I	 S	 S	 		 S	 S	 S	 S	 I	 S	
11
2	 73	
FD01844
594	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 m	 Kenyariri	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	
Typhimuriu
m	 19	
Resistant	to	
streptomyci
n	and	
tetracyline	 S	 S	 R	 R	 S	 S	 S	 S	 S	 S	 S	 S	
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11
2	 342	
FD01844
614	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 m	
Kenyarir
i	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	
Typhimuriu
m	 19	
Resistant	to	
streptomyci
n	and	
tetracycline	 S	 S	 R	 R	 S	 S	 S	 S	 S	 S	 S	 S	
13
1	
100/4
03	
FD01844
623	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Kingero	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 n	 y		 Braederup	 22	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
18
2	 88	
FD01844
641	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Wangige	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	
Typhimuriu
m	 313	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
18
6	 325	
FD01844
592	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 ?	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
19
1	 386	
FD01543
507	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Wangige	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
HA
C	 		 y	 y	 Heidelberg	 15	 Susceptible	 s	 s	 i	 s	 s	 s	 s	 s	 i	 s	 s	 s	
21
4	 339	
FD01844
608	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Homa	
Bay	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 No	serovar	 ND	 Susceptible	 		 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
21
5	 11	
FD01543
562	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Homa	
Bay	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
21
5	 326	
FD01844
600	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 f	
Homa	
Bay	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
BG
A	 y	 y	 y	 Fulica	
106
3	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
21
8	 385	
FD01543
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Nairo
bi	
unkno
wn	
Landra
ce	
cross	 m	 Dandora	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
BG
A	 y	(b+g)	 y	 y	
new	
serovar/Nair
obi	
120
8	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 I	 S	 S	 S	 S	
22
4	 351	
FD01844
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Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Kabete	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
BG
A	 y	 y	 y	 Heidelberg	 15	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	
24
6	
407/5
8	
FD01543
496	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Kabete	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
HA
C	 y	 n	 y		 Heidelburg	 15	 Susceptible	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	 S	
24
7	 67	
FD01543
523	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Homa	
Bay	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
F	
HA
C	 y	 y	 y	 Heidelberg	 15	
Resistant	to	
kanamycin	 S	 S	 I	 S	 S	 R	 S	 S	 I	 S	 S	 S	
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24
7	 367	
FD01844
590	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Homa	
Bay	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 y	 y	 y	 Virchow	 16	 Susceptible	 S	 S	 I	 S	 S	 S	 S	 S	 I	 S	 S	 S	
26
2	 18	
FD01844
655	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	
Unknow
n	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 Y	 y	 y	 Anatum	 64	 Susceptible	 S	 S	 I	 S	 S	 I	 S	 S	 S	 S	 S	 S	
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2	 359	
FD01844
645	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	 f	 Gathiga	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	 F	 y	 y	 y	
Typhimuriu
m	 19	 No	results	 		 		 		 		 		 		 		 		 		 		 		 		
45	 380	
	
FD01543
587	
Nairo
bi	
unkno
wn	
Landra
ce	
cross	
unkno
wn	 Gatwiga	
Ndumboini	
slaughterh
ouse	
Pickup	
truck	
Unkno
wn	
ML
N	
HA
C	 	 y	 y	 new	serovar	
120
8	 Susceptible	 I	 S	 S	 S	 S	 S	 S	 S	 S	 S	 s	 s	
		 296	
FD01543
580	 Busia	
unkno
wn	
Unkno
wn	
Unkno
wn	
Unknow
n	 Unknown	
Motorb
ike	
Unkno
wn	
ML
N	
BG
A	
Unkno
wn	
Unkno
wn	
Unkno
wn	 Offa	
-
319	 Unknown	 		 		 		 		 		 		 		 		 		 		 		 		
	
Table	I;	Complete	table	of	all	positive	NTS	isolates	returned	from	sequencing.	Text	in	bold	indicates	one	of	each	of	the	pairs	of	duplicate	isolates	(i.e.	those	
originating	from	the	same	location,	in	the	same	pig,	with	identical	sequence	type,	serovar	and	antimicrobial	resistance	phenotype.	Isolates	not	recorded	in	
bold	text	are	‘unique’	isolates.	All	of	the	unique	isolates,	although	they	may	originate	from	the	same	pig	or	sampling	location	have	some	difference	either	in	
sequence	type,	serovar	or	antimicrobial		
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Map	I:	Location	of	slaughterslabs	in	Busia	county	
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Map	II;	Location	of	rearing	of	NTS	positive	pigs	sampled	in	Busia	
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Map	III:	Locations	of	sample	collection	in	the	Chikwawa	Valley,	Malawi	
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Map	IV;	Locations	of	rearing	of	NTS	positive	pigs	sampled	in	Ndumbuini	slaughterhouse,	Nairobi	
Ndumbuini	Shops=	location	of	Ndumbuini	slaughterhouse		
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Map	V;	Location	of	rearing	of	NTS	positive	pigs	sampled	around	Nairobi	(see	Key	for	Map	IV	above)	
